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1.1.1 Trypanosoma brucei as Pathogen of Sleeping Sickness and Nagana 
 
Trypanosomes are monocellular, parasitic eukaryotes. Since the beginning of 
last century, they have been well known as pathogens of some tropical diseases 
of human and animals. Sleeping sickness of human is caused by Trypanosoma 
brucei gambiense (Dutton, 1902) and Trypanosoma brucei rhodesiense 
(Stephens & Fantham, 1910). These two subspecies are similar in morphology, 
however, they differ in the type of diseases been caused. T. brucei rhodesiense 
causes the acute form of trypanosomiasis in East Africa, whereas T. brucei 
gambiense induces the chronic form of trypanosomiasis in West Africa. The 
acute sleeping sickness leads to death after a few months and the chronic form 
results to death within 3 years if the illness is not been treated. According to the 
report of World Health Organization (WHO), about 55 million Africans live in 
endemic regions, and about 500,000 people are newly infected every year. 
 
The third subspecies, known as Trypanosoma brucei brucei, is not pathogenic 
for human, because this parasite is lysed by a component of the human serum 
(haptoglobin of HDL) (Hajduk & Hager, 1994). It infects domestic animals 
(cattle, sheep, dogs, pigs and goats) and many other wild animals. The 
trypanosomiasis caused in domestic animals has important economic 
significance (Nagana).  
 
All these trypanosomiases are transmitted by the tsetse fly, which injects the 
infective metacyclic forms into the blood during feeding. The sleeping sickness 
and Nagana-plague are restricted to tropical Africa in a breadth of 15 degree 
North and 18 degree South (Tsetse-belt) (Dönges, 1988).  
 
There are available chemical therapies (suramine or berenil, respectively) 
against sleeping sickness and Nagana-plague in the early stage of infection. 
Treatment becomes very difficult, however, in the later stages of the infection 
because of side effects and the limitation of α-difluoromethylornithine (DFMO) 
in treatment of T. b. gambiense infection (Doua & Boa-Yapo, 1994). 
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Study of the metabolism of T. brucei has therefore significance for the 
development of new anti-trypanosome medicine. Although the pathogenic 
species have received most attention for the disease they cause, these organisms 
have also provided good models for the study of various fundamental biological 





Trypanosome belongs to the family Trypanosomatidae. The genus Trypanosoma 
consists of blood or tissue parasites of vertebrates with invertebrate intermediate 
hosts. Hoare (1966) divided the genus Trypanosoma into two sections: A. 
stercoraria, B. salivaria, on the basis of whether they develop in the hindgut or 
in salivary glands of the insect vector. The species T. brucei belongs to the 
salivaria section. The following classification is based on Levine et al. (1980): 
 
Phylum  Protozoa 
Subphylum  Sarcomastigophora 
Class    Mastigophora 
Subclass  Zoomastigophora 
Order   Kinetoplastida 
Family  Trypanosomatidae 
Genus  Trypanosoma 
Species  Trypanosoma brucei 
Subspecies  Trypanosoma brucei brucei    (non human pathogenic) 
   Trypanosoma brucei gambiense (human pathogenic) 
   Trypanosoma brucei rhodesiense (human pathogenic) 
 
 
1.1.3 Life Cycle  
 
Transmission from one vertebrate host to another is carried out by blood-
sucking invertebrates, usually an insect. Shortly after infected blood enters   
insect gut, bloodstream forms become transformed into insect gut forms; the 
latter give rise to the epimastigote forms and finally metacyclic forms. Upon an 
insect bite, the tsetse fly deposit metacyclic trypanosomes in the dermal 
connective tissue, inducing a local inflammatory reaction. From this region the 
parasite migrates to the lymphatic and hence to the bloodstream. From these 
sites, after undergoing intense multiplication, they penetrate the blood and 
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lymph capillaries, into the connective tissue and, after a month or so, cross the 
choroids plexus into the brain and cerebrospinal fluid. In the early stages of 
infection 'slender' forms predominate, eventually they give way to 'stumpy' 
forms via an 'intermediate' form stage. The invasion of the nervous system 
results in 'sleeping sickness', characterised by a general physical and mental 
depression and a desire to sleep. T. b. gambiense produces a chronic human 
disease that may last for several years before ending in death. In contrast, the 
disease caused by T. b. rhodesiense is an acute disease, which lasts for about six 
months before terminating fatally. The only difference between these species 





A typical 'trypanosome' is an elongated organism, 15-30 µm in length (including 
flagellum) and 1.5-3 µm in width, with a single nucleus containing a large 
central nucleolus (karyosome). Movement is effected by a single flagellum, 
which originates in the basal body. In addition to a plasma membrane, an 
outside coat covering this membrane consists of about 107 virtually identical 
copies of a single glycoprotein known as variant surface glycoprotein (VSG). 
There are up to several hundreds genetically encoded variants of VSGs, which 
can be sequentially expressed. VSG apparently protects the parasite from the 
host’s immune attack. In all trypanosomes this glycoprotein coat is lost after 
entering the vector. The endoplasmic reticulum is represented by tubules, which 
emerge from the nuclear envelope and ramify though the cytoplasm. The Golgi 
apparatus is generally located anteriorly opposed to the cytopharynx. It has the 
usual eukaryote structure with stacks of cisternae. The kinetoplast is a 
filamentous body, which contains kinetoplast DNA and has been shown to be 
part of the mitochondrion. Unlike mitochondria DNA of other cells, the 
synthesis of kinetoplast DNA is temporarily linked to nuclear DNA synthesis. 
Ultra structure studies have revealed marked cytological and metabolic 
differences between the bloodstream and fly gut forms (Vickerman, 1962, 
1985). In the slender bloodstream forms, the mitochondrion forms one single 
tube extending the length of the body, with few cristae present. In contrast, in 
the fly gut form, the mitochondrion takes the form of an extensive tubular 
network with well- developed cristae. 
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Fig. 1.1: Cell Structure of the Long Slender Blood form of Trypanosoma brucei  




1.1.5 Unusual Features 
 
Trypanosomes have excited the interest and attention of molecular biologists, 
immunologists and geneticists on account of a number of unusual features. 
Probably due to the early divergence of this eukaryotic lineage in evolution, 
studies of the molecular biology of this cells have produced a plethora of novel 
and significant discoveries, which include polycistronic transcription, trans-
splicing of precursor mRNAs, the presence of an unique organelle containing 
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most of the glycolytic enzymes, editing of mitochondrial mRNAs by uridine 
insertion/deletion, antigenic variation and glycosylphosphatidylinositol anchors 
of membrane proteins. All of these make them interesting models for the study 




1.2 VSG-Surface Coat 
 
 
1.2.1 Antigenic Variation  
 
The surface coat of the bloodstream form of African trypanosomes is arranged 
as a dense monolayer of homodimers on the parasite surface. The ability of the 
surface coat of trypanosomes to undergo continuous antigenetic variation results 
in the escape from the host's immune response. The surface antigens change 
every 8 ~ 10 days after the trypanosome entered the vertebrate host. Specific 
antibodies produced by the host are no longer effective owing to the appearance 
of new variant surface antigens (VSGs). The exchange of VSG is based on the 
sequential expression of several hundreds different VSG genes (Van der Ploeg, 
1982). The actively transcribed gene is always located in a VSG expression site, 
which is in a polycistronic transcription unit on the telomer of a chromosome. 
There are probably 20~40 expression sites within the genome, but only one of 
them is active at a given time. The switching to another VSG is effected by two 
different ways. One is by in situ activation of a new expression site; the other is 
by the rearrangement of the DNA on the active expression site.  
 
 
1.2.2 Molecular Structure of the VSG 
  
The VSG is attached to the plasma membrane by means of a 
glycosylphosphatidylinositol (GPI) anchor. VSG consists of 2 domains, one N-
terminal domain with 350~400 amino acids and one C-terminal domain with 
50~100 amino acids (Carrington & Boothroyd, 1996) and has at least one N-
linked oligosaccharide, although the position of this oligosaccharide varies 
(Cross, 1984; Turner & Barry , 1989). The carbohydrate content varies from 7 to 
17% in a range of glycoproteins studied (Johnson & Cross, 1977). The sequence 
of the N-terminal domain is extremely diverse except for the relative location of 
cysteine residues, which are conserved (Cross, 1984). The C-terminal domain 
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exhibits some degree of sequence conservation (Holder & Cross, 1981). VSGs 
are found as dimers in solution (Auffret & Turner, 1981) and are believed to 




1.2.3 Biosynthesis of VSG  
 
Precursors of GPI anchored proteins have a classical signal sequence at their N-
terminus and a GPI anchoring signal at their C-terminus. The N-terminal signal 
directs the nascent polypeptide through the rough endoplasmic reticulum 
membrane and is removed as a co-translational event (McConnell et al., 1981). 
N-glycosylation appears to occur cotranslationally, but in a few cases N-
glycosylation was delayed or incomplete (Ferguson et al., 1986). The C-terminal 
signal is necessary and sufficient to direct GPI addition  (Caras et al., 1987; 
Moran & Caras, 1991; Moran et al., 1991; Kodukula et al., 1993). After 
completion of the polypeptide, the C-terminal GPI anchoring signal is removed 












glycan structure in the GPI-anchor
 
 








1.2.4 N-Glycosylation of VSG 
 
VSGs may be grouped into 3 sub-types based on C-terminal sequence 
homologies (Carrington et al, 1991). Each VSG variant contains one, two or 
three N-linked oligosacchrides (Zamze, 1990; 1991). Type I VSGs contain one 
conserved N-glycosylation site about 50 residues from the mature C-terminus 
and contains oligomannose structures. Type II VSGs generally contain two 
glycosylation sites, one 5 or 6 residues from the mature C-terminus and the other 
about 170 residues from the mature C-terminus. The first site contains a mixture 
of oligomannose structures and larger polylactosamine-containing structures. 
The latter site is occupied by small structures like Man3-4GlcNAc2 and 
GlcNAcMan3GlcNAc2 or regular biantennary complex glycans. The one 
characterized type III VSG (MITat 1.5) contains three potential N-glycosylation 
sites (123, 356 and 377 residues from the mature C-terminus) consisting of a 
mixture of oligomannose and complex biantennary structures. The larger 
polylactosamine-containing structures and regular biantennary complex glycans 
contain galactose residues and linked to GlcNAc in a β1,4 glycosidic linkage. 
The observed differences in GPI anchor galactosylation (see 1.3.1) and N-glycan 
number and structure appear to correlate with VSG sub-classes. Therefore, it 
seems that the carbohydrate is used as space-filling material to compensate for 
differences in the VSG three-dimensional structures and to ensure the barrier 
characteristics of different VSG coats.  
 
 
1.2.5 Transport of VSG to the Cell Surface, VSG-Recycling and Shedding 
 
Intracellular transport of VSG to the cell surface occurs with a half time of about 
15 min, where it is integrated into the surface coat by budding and fusion of 
small vesicles. VSG transport follows the classical secretory pathway: ER, Golgi 
apparatus, and delivery to the flagella pocket, where it is integrated into the 
surface coat. Incubation of trypanosomes at 20°C, a treatment that arrests 
intracellular transport from the trans-Golgi region to the cell surface in 
mammalian cells, caused the accumulation of VSG molecules in structures of 
the trans-Golgi network, and retarded the incorporation of newly synthesized 
VSG into the surface coat (Duszenko et al., 1988). VSG uptake by endocytosis 
was found to occur exclusively along the flagella pocket membrane and was 
related to the formation of coated pits and coated vesicles in this functionally 
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discrete surface domain. More than 95% of the endocytosed surface VSG is 
recycled back to the plasma membrane. Turnover and removal of old VSG are 
performed by VSG shedding at a rate of 2.2%/hr. After 7 days 87% and after 8 
days 99% of the switched cell population has released all old VSG and is 




1.3 GPI Anchor 
 
 
1.3.1 Structure of the GPI Anchor 
 
The GPI anchoring pathway seems to have been elaborated early in evolution 
since the core carbohydrate structure linking the protein to the lipid moiety is 
identical in all GPI anchors, namely protein-CO-NH-(CH2)2-PO4-6Manα1-
2Manα1-4GlcNH2-myo-inositol-PO4-lipid (McConville & Ferguson, 1993). 
This backbone is common to all GPI-anchored proteins found in eukaryotes, but 
is variously modified by side structures in different organisms and cell types 
(McConville & Ferguson, 1993). The structure of the inositol phospholipid also 
varies in different organisms. Trypanosoma brucei exclusively uses dimyristyl 
phosphatidyl-inositol at the blood stage and lysophosphatidylinositol at the 
insect stage. Cleavage of a GPI membrane anchor with bacterial PI-PLC (or 
eukaryotic GPI-PLC) leads to the formation of the inositol 1,2-cyclic 
monophosphate, which appears to be the major epitope involved in the cross 
reactivity of GPI anchored proteins (Zamze et al., 1988) (Fig. 1.3). The mannose 
residue next to glucosamine may be galactosylated. These α-Gal side-chains of 
the VSG GPI anchor are unusual structures, which appear to be restricted to 
African trypanosomes (Ferguson et al., 1988). Type I VSGs (MITat 1.4, MITat 
1.6) contain 4 galactose residues per GPI molecule, type II VSGs (MITat 1.2) 
contain 8 galactose residues and type III VSGs (MITat 1.5) contain no galactose 
residue (Holder, 1985). The α-galactosylation machinery of African 
trypanosomes may be involved specifically to optimize the packing of different 
VSG coats, and therefore may increase the viability in the presence of host 
serum complement. 
 
































Fig. 1.3: Schematic Representation of the Structure of GPI Anchor and the Cross-
reacting Determinant (CRD) 
 
E: ethanolamine  I: inositol  P: phosphate 
G: glucosamine  M: mannose 
 
 
1.3.2 Biosynthesis of the GPI Anchor 
 
The relative abundance of the VSG protein in Trypanosoma brucei has made 
this organism extremely useful for the study of GPI anchor biosynthesis. The 
structure of the VSG GPI anchor is known (Ferguson et al., 1988) and principal 
features of the GPI biosynthetic pathway in trypanosomes were elucidated using 
a cell-free system based on washed trypanosome membranes (Masterson et al., 
1989, 1990; Menon 1990). The GPI anchor precursors are synthesized in the 
outside of endoplasmic reticulum membranes by sequential addition of sugar 
and other components to phosphatidylinositol (Ferguson, 1992; Menon & 
Vidugiriene, 1994). More than ten genes participate in this biosynthetic 
pathway. First, the α-GlcNAc is transferred from UDP-GlcNAc to PI to form 
GlcNAc-PI, which is subsequently de-N-acetylated to GlcN-PI (Doering et al., 
1989). Then three mannose residues are transferred from Dol-P-Man to GlcN-PI 
to form Man3GlcN-PI (Menon et al., 1990). EtN-P is added to position 6 of the 
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third mannose from phosphatidylethanolamine, generating NH2-(CH2)2-PO4-
6Manα1-2Manα1-4Glc-NH2-myo-inositol-PO4-lipid. This molecule represents 
the mature GPI anchor precursor and is transferred to VSG en bloc.  
 
 
1.4 In vitro Translation System 
 
 
1.4.1 General Features of the in vitro Translation System 
 
Cell-free protein synthesizing systems have contributed significantly to the 
understanding of the molecular mechanisms involved in post-transcriptional 
regulation of gene expression and co- and post-translational modification of 
proteins. Although a large number of different protein-synthesizing systems 
have been used, most of the data were collected using rabbit reticulocytes, wheat 
germ and E.coli lysates. There are some other in vitro translation system 
developed from such as Saccharommyces cerevisiae (Doering & Schekman, 
1997), Candida albicans (Colthurst et al., 1991), rat hepatocytes (Kimball et al., 
1989), Hela-cells (Carroll & Lucas-Lenard, 1993) and Crithidia (Cross, 1966; 
Ilan & Ilan, 1970). The biosynthesis of certain Trypanosoma brucei proteins has 
previously been studied using either reticulocyte lysates (McConnell et al., 
1981, 1982, 1983; Presper et al., 1986) or wheat germ extracts (Mowatt et al., 
1988; Cornelissen et al., 1986). Translation of VSG has been studied in several 
cell-free systems. In reticulocyte lysates supplemented with dog pancreatic 
microsomes, VSG containing some N-linked glycans could be produced 
(Presper & Heath 1986). This system supplemented with trypanosomal 
microsomes did not result in glycosylation (Moreno & Cross, 1991). In none of 
these systems GPI anchoring was observed, however. Post-translational 
modifications of VSG may thus only occur in a homologous cell-free system.  
 
 
1.4.2 Translation in Trypanosome Lysates 
 
A cell-free system from the bloodstream form of Trypanosoma brucei was first 
demonstrated by Moreno & Cross, 1991. Here VSG synthesized from 
endogenous mRNA was co-translational N-glycosylated, but reinitiation was 
rather poor and no signal sequence cleavage or glycosylation did occur. 
Therefore, we have developed an in vitro translation system in our laboratory. 
However, standard preparation protocols have failed to produce an active in 
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vitro translation system. In fact, the translation activity of reticulocyte lysate 
could be inhibited by addition of this trypanosome lysates. Through 12 to 24 h 
dialysis or ultracentrifugation, an endogenous translational active retentate was 
obtained (Miosga, 1989; Landgraf, 1990). By addition of 2-aminopurine and 
spermidin, the translation activity was further improved (Bernhagen, 1992). The 
inhibitor problem was thoroughly solved by Lehner and Hömke (1995, 1997). 
They applied a method called ‘limited lysis’. After 7 min hypotonic 
homogenization and isotonic adjustment, the lysate was immediately centrifuged 
(6 min, 12000g, 4°C) to prevent the release of a potent small molecular mass 




1.5 The Anchor Exchange Enzyme Complex 
 
 
1.5.1 Supposed Reaction Mechanism 
 
The use of prepromini-placental alkaline phosphatase (MiniPLAP) as substrate 
led to as much as 10% of the mature product that was cleaved correctly but was 
not linked to the GPI anchor (Maxwell et al., 1995). Some of the factors that 
influenced the relative proportions of GPI linked to free miniPLAP have been 
the amount of GPI in the cells and the amino acid substituent at the ω site of the 
nascent protein. GPI was also necessary even for the formation of free 
miniPLAP. These results supported a transamidase type of enzyme, which forms 
an activated intermediate with the carbonyl group of the amino acid at the ω site 
of pro-peptide. This activated intermediate accepts the nucleophilic amino group 
of the ethanolamine residue of GPI to form GPI-linked mature miniPLAP or an 
abundant nucleophile such as water to yield free mature miniPLAP. Direct 
evidence for a transamidase has been inferred from the finding that a 
microsomal enzyme activity capable of removing the C-terminal GPI anchor 
signal was enhanced by small nucleophilic amines (Maxwell et al., 1995). The 
experiments revealed that hydrazine and hydroxylamine, in the presence of 
rough microsomal membranes, catalyze the conversion of the pro form of 
miniPLAP to mature form from which the COOH-terminal signal peptide has 
been removed, apparently at the same site but without the addition of GPI. 
When a biotinylated derivative of hydrazine was used instead of hydrazine, the 
released VSG could be precipitated with streptavidin-agarose, indicating that the 
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biotin moiety was covalently incorporated into the protein. Hydrazine was 
shown to block the C terminus of the released VSG hydrazide because the 
released material, unlike a truncated form of VSG lacking a GPI signal 
sequence, was not susceptible to proteolysis by carboxypeptidases. (Sharma et 
al., 1999) These results showed that the released material is VSG hydrazide and 




Fig. 1.4: Proposed Mechanism of the Transamidase Mediated Anchor Exchange      
Reaction 
(According to Udenfriend et al., 1995 and Sharma et al., 1999) 
 
The carbonyl group of the amino acid (aspartic acid) of pro-VSG is activated by a sulfhydryl 
group in the transamidase (Enz-S) resulting in the formation of an enzyme-substrate complex 
and cleavage of the amide bond between aspartic acid and serine (ω+ 1 in the c-terminal 
signal sequence of pro-VSG). Nucleophilic attack by H2N-X results in release of VSG-NH-X 
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In Trypanosoma brucei the reaction could be inhibited with sulfhydryl 
alkylating reagents, suggesting that the transamidase enzyme contains a 






Genetic approaches have identified genes required for addition of GPI precursor 
lipids to proteins. Transamidase-deficient cells are expected to accumulate 
complete GPI lipids as well as GPI precursor proteins. This phenotype is 
exhibited by two yeast mutants, Gaa1 and Gpi8, and a mammalian mutant cell 
line (class K) (Mohney et al., 1994; Hamburger et al., 1995; Benghezal et al., 
1995; Yu et al., 1997; Chen et al., 1996). GPI8 is an essential yeast gene and 
encodes a type I transmembrane ER protein with a large luminal domain. Yeast 
Gpi8 has 27.5% identity to jack bean asparaginyl endopeptidase, which shows 
transpeptidase activity in vitro (Abe et al., 1993). It belongs to a novel cysteine 
protease family. Homologies between this family and other Cys proteinases, 
such as caspases, pointed to Cys199 and His157 as potential active site residues. 
Indeed, Gpi8 alleles mutated at Cys199 or His157 are nonfunctional, i.e., they 
are unable to suppress the lethality of ∆gpi8 mutants (Meyer et al., 2000). The 
homology with proteases suggests that Gpi8 is directly involved in the 
proteolytic removal of the GPI-anchoring signal. The protein contains three N-
glycosylation sites. In contrast to Gaa1, which contains KKXX or KXKXX 
retrieval signals at their cytosolic C-terminal ends, Gpi8 does not contain any 
known retrieval sequence. Gpi8 may be retained in the ER through an 
interaction with other ER resident proteins or may contain an unidentified 
retention motif. It is also possible that Gpi8 is retained in the ER by an 
interaction with Gaa1 since Gaa1 coprecipitated with Gpi8 (Ohishi et al., 2000).  
 
 
1.5.3 GAA1 and Other Components 
 
The GAA1 gene is also essential and codes for a 68 kDa ER protein with a large 
luminal domain, several membrane spanning domains and a cytosolic ER 
retrieval signal on the far end of the C terminus. A Saccharomyces cerevisiae 
gaa1 mutant was defective in posttranslational attachment of GPI to proteins 
(Hamburger et al., 1995). GAA1 knockout cells were defective in the formation 
of carbonyl intermediates between precursor proteins and transamidase as 
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determined by an in vitro GPI-anchoring assay. Human and mouse GAA1 genes 
consist of twelve exons that span about 4 kb. Human and mouse GAA1s are 
located at 8q24.3 or 15E (chromosome position), respectively (Inoue et al, 
1999). The amino acid sequence of hGaa1 is 25% identical and 57% 
homologous to that of yeast Gaa1 (Hiroi et al., 1998). Gaa1 and Gpi8 are 
associated with each other and constitute a GPI transamidase (Ohishi et al., 
2000).  Gaa1 has no homology to other proteins in the databases. This protein is 
required for the attachment of GPIs to proteins in vivo although its exact role is 
still unknown. Amino acids 311-321 of yeast Gpi8 are essential for GPI 
attachment. This region is not necessary for association of Gpi8 with Gaa1, 




1.6 Objective of this Work 
 
The work embodied here envisages different approaches employed for co- and 
posttranslational processing of VSG. One of the objectives of this work was to 
use the in vitro translation system and in vitro culture of the bloodstream form of 
Trypanosoma brucei for the study of N-glycosylation and GPI-anchor exchange. 
The established cell-free system could incorporate radio labeled amino acids 
into newly formed proteins with high efficiency similar to reticulocyte lysates. 
The newly formed VSG was analyzed to testify the processing capability of the 
in vitro translation system. The reaction mechanism was studied using small 
nucleophilic amines. Although the transfer of preformed GPIs onto proteins can 
be studied by the in vitro translation system, the enzymes involved in this 
process have not been fully characterized, yet. The GPI-transferase complex is 
believed to act as a transamidase. Two yeast mutants, Gaa1 and Gpi8, 
accumulate complete GPIs as well as the GPI precursor proteins. These proteins 
are required for the attachment of GPIs to proteins. Therefore, Trypanosoma 
brucei GPI8 was to be cloned and the recombinant protein should be 
heterologously expressed in E. coli to check for the activity and to generate 
specific antiserum. This specific antiserum should be used to testify for cell 
localization of TbGpi8, Western blotting analysis and immunoprecipitation of 
the GPI-transferase complex. 
 











2.1.1 General Chemicals 
 
Acrylamide (Rotiphorese Gel 30) ROTH, Karlsruhe 
Agar-Agar   ROTH, Karlsruhe   
Agarose      FMC 
2-Aminopurine     Sigma, Deisenhofen 
Ampicillin      ROTH, Karlsruhe 
AmplifyTM      Amersham Buchler, Braunschweig 
Amylose resin     NEB GmbH Schwalbach/Taurus 
Albumin, Bovine (BSA)    Sigma, Deisenhofen 
Ammonium persulphate (APS)   Merck, Eurolab GmbH Germany 
ATP       Sigma, Deisenhofen 
UltraLinkTMImmobilized 
NeutrAvidinTMPlus    Pierce, Illinois, USA 
Bisbenzimide     Sigma, Deisenhofen 
Bromophenol blue    ROTH, Karlsruhe 
Chitin beads     NEB GmbH Schwalbach/Taurus 
Chymostatin     Sigma, Deisenhofen 
Coomassie brilliant blue G-250  ROTH, Karlsruhe 
Creatin phosphate     Sigma, Deisenhofen 
DEAE-Sephacel     Sigma, Deisenhofen 
Dimethyl sulfoxide (DMSO)   Sigma, Deisenhofen 
1kb DNA ladder     NEB GmbH Schwalbach/Taurus 
100 bp DNA ladder    NEB GmbH Schwalbach/Taurus 
dNTPs      Sigma, Deisenhofen 
DTT       ROTH, Karlsruhe 
EDTA      ROTH, Karlsruhe 
Ethidium bromide     ROTH, Karlsruhe 
Formaldehyde (37%)    Sigma, Deisenhofen 
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Freunds adjuvant,  
'complete' and 'incomplete' Sigma, Deisenhofen 
Glycerol ( 87%)     Merck, Eurolab GmbH Germany 
Glycine      Merck, Eurolab GmbH Germany 
GTP       Sigma, Deisenhofen 
Haemin     Sigma, Deisenhofen 
HEPES      Sigma, Deisenhofen 
Ni-NTA agarose     Qiagen GmbH, Hilden 
Hydrazine-hydrate    Sigma, Deisenhofen 
Imidazol      Merck, Eurolab GmbH Germany 
Isopropanol      Merck, Eurolab GmbH Germany 
L-Isoleucine     Sigma, Deisenhofen 
Isopropyl β-D-thiogalactopyranoside 
(IPTG)    Sigma, Deisenhofen 
Leupeptin      Sigma, Deisenhofen 
MEM vitamine solution    Sigma, Deisenhofen 
Protein molecular marker Sigma, Deisenhofen    
BenchMarkTM prestained protein ladder Gibco BRL Life Technology, Karlsruhe 
n-Octyl-D-glucopyranosid Sigma, Deisenhofen    
Pepstatin A Sigma, Deisenhofen    
Pfu-Polymerase buffer Stratagene Europe Netherland   
Phenol ROTH, Karlsruhe    
Polyethylene glycol 6000 (PEG 6000) ROTH, Karlsruhe  
Restriction enzyme buffer NEB GmbH Schwalbach/Taurus  
RNasinribonuclease inhibitor, 40U/ml Promega, Madison, USA 
Sepharose 4B, CNBr-activated Sigma, Deisenhofen    
Sodium dodecyl sulfate (SDS)   Serva, Heidelberg 
SuperSignal West Pico 
Chemiluminescent substrate Pierce, Illinois, USA    
Taq-polymerase buffer Sigma, Deisenhofen    
T4-ligase buffer Gibco BRL Life Technology, Karlsruhe   
TEMED ROTH, Karlsruhe     
Tris-hydroxymethyl-aminomethane 
(Tris) Serva, Heidelberg  
Triton X-100 Sigma, Deisenhofen    
 
__  Materials and Methods ____________________________________________ 17 __ 
 
 
Tunicamycin Sigma, Deisenhofen    
Tween 20 ROTH, Karlsruhe     
Ultima GoldTM Scintillation cocktail Packard, Frankfurt a.M.   
Urea Merck, Eurolab GmbH Germany  
Yeast extract ROTH, Karlsruhe     





L-[35S]-methionine    ICN, Eschwege 





Agarose gel elution kit    Roche Boehringer Mannheim GmbH 
ECLTM in vitro translation system  Amersham Buchler, Braunschweig 
Biotin-lysine-tRNAlys Set   Roche Boehringer Mannheim GmbH 
IgY purification kit    ACROS Organics, Belgien 
 
 
2.1.4 Enzymes and Antibodies 
  
alk. phosphatase (CIP)    NEB GmbH Schwalbach/Taurus 
EcoRI      NEB GmbH Schwalbach/Taurus 
EcoRV      NEB GmbH Schwalbach/Taurus 
Enterokinase     Roche Böhringer Mannheim GmbH  
KpnI       NEB GmbH Schwalbach/Taurus 
Creatinkinase     Serva, Heidelberg 
NdeI       NEB GmbH Schwalbach/Taurus 
N-glycosidase F (PNGase F)   Roche Böhringer Mannheim GmbH 
NheI       NEB GmbH Schwalbach/Taurus 
Nuclease S7 from Staphylociccus 
aureus  Roche Böhringer Mannheim GmbH 
Pfu-polymerase     Stratagene Europe Netherland 
Polynucleotidkinase    NEB GmbH Schwalbach/Taurus 
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RNase A      Sigma, Deisenhofen 
SapI       NEB GmbH Schwalbach/Taurus 
Taq-polymerase     Sigma, Deisenhofen  
T4 polynucleotide kinase  NEB GmbH Schwalbach/Taurus 
T4-DNA-ligase     NEB GmbH Schwalbach/Taurus 
XhoI       NEB GmbH Schwalbach/Taurus 
Anti-rabbit-IgG peroxidase conjugate Sigma, Deisenhofen 
Anti-rabbit-IgG FITC conjugate   Sigma, Deisenhofen 
Anti-rabbit-IgG gold conjugate Sigma, Deisenhofen 
Anti-mouse-IgG peroxidase conjugate Sigma, Deisenhofen 
Anti-mouse-IgG FITC conjugate  Sigma, Deisenhofen 
Anti-chicken IgG peroxidase conjugate Sigma, Deisenhofen 
Anti-chicken IgG FITC conjugate  Sigma, Deisenhofen 
Anti-chicken IgG gold conjugate  Sigma, Deisenhofen 
Anti-CRD serum from rabbit   gift of T. Ilg (MPI for Biology, Tübingen, Germany) 






Biofuge A      Heraeus, Osterode 
Microfuge E     Beckmann, München 
Sigma 302K Labor Centrifuge   Sigma, Deisenhofen 
Suprafuge 22 with Rotor HFA 22.50  Heraeus, Osterode 
Table Centrifuge Denver Force 13  Denver Instrument Company, Arvada, USA 
 
Electrophoresis and Western Blotting 
Electrophoresis Minigel System 
'Mighty Small II' SE 250  
Hoefer Scientific Instrument, San 
Francisco, USA 
Semi-Dry Eletrophoretic transfer Cell BioRad, München  









Filtration Apparatus 1225 Sampling 
Manifold  Millipore, Bedford, USA 
Liquid Scintillation Counter LSC 1600 
CA   Packard, Frankfurt a.M 
 
  
2.1.6 Experimental Organisms 
 
Trypanosoma b. brucei 
MITat 1.2     221 of strain EATRO 427 
MITat 1.4     117 of strain EATRO 427 
MITat 1.5     118 of strain EATRO 427 
 
E. coli 
XL-1 Blue      Stratagene Europe Netherland 
ER2566      NEB GmbH Schwalbach/Taurus 
 
 
2.1.7 Other Consumable Materials 
 
BioMax MR-1 scientific imaging film Kodak, Stuttgart 
BioMax Light-1 scientific imaging film Kodak, Stuttgart 
Dialysis tube     Serva, Heidelberg 
Glasfaser filter GF/C    Whatman, Maidstone, USA 
HybondECLTM nitrocellulose 
membrane Amersham, Braunschweig 
Microcon 30 ultrafiltration units  Amicon, Witten 
Microplate      Nunc, Denmark 
Object plate for immunofluorescence  bioMĕrieux, France 
Parafilm      American Can Co., Chicago 
Sterile tube, Falcon, 15ml, 50ml  Becton Dickingson, New Jersey 
Whatman 3MM paper    Whatman, Maidstone, USA 
Sterile filter SFCA-membrane   Nalge, Hereford (UK) 
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2.1.8 Vectors and Primers 
 
Vectors 
pBS KS+      Stratagene Europe Netherland 
pTYB1      NEB GmbH Schwalbach/Taurus 
pMALTM-c2      NEB GmbH Schwalbach/Taurus 
pRSET B      Invitrogen, Karlsruhe    
pEGFP-N1      Clontech, California, USA 
 
 
Primers      Sequence 












  CTCTAC-3’  
 
His-tag expression system for GPI8 





Intein expression system for GFP-221VSG 
221-PEPSE  5’-GATATACATATGCTGGAGGGCAATGCCAAGTTA 
   ACGACTATAC-3’ 
221-PEPAS  5’-AAGCCAAAGAGGGGTCTTGCT-3’ 
3GFP-NDE  5’-CGCTACATATGCTTGTACAGCTCGTCCATGCCG 
   AG-3’ 
5GFP-NDE  5’-CGCTACATATGGTGAGCAAGGGCGAGGAGCTG-3’ 
 




221-5ADA  p-GCAGTTTTGCTTTTT 
221-3ADA  p-GCAAAAAAGCAAAACTGC 
    
 
 
2.2  Media, Buffers and Solutions 
 
 
2.2.1 Cultivation and Isolation of Trypanosomes 
 
Citrat-Glucose-Anticoagulant (CGA) pH 7.7 
  Na3-citrate x 2H2O     100 mM 
  Glucose        40 mM 
 
Separation buffer, pH 8.0 (Lanham & Godfrey, 1970) 
  Na2HPO4 x 2H2O      57 mM 
  KH2PO4         3 mM 
  NaCl        44 mM 
  Glucose       55 mM 
 
Basic medium, pH 7.4  
(According to Eagle, 1959; modified by Duszenko et al., 1985, 1992) 
          [mg/l] 
  CaCl2 x H2O      265 
  KCl        400 
  MgSO4 x 7H2O      200 
  NaH2PO4 x H2O      140 
  NaCl        6800 
  HEPES       7140 
  Phenol Red       10 
These chemicals were dissolved in water and the pH was adjusted to 7.4. 
 
  L-Arginine/HCl      126 
  L-Cysteine       24 
  L-Histidine/HCl x H2O     42 
  L-Isoleucine      52 
  L-Leucine       52 
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  L-Lysine       73 
  L-Methionine      15 
  L-Phenylalanine      100 
  L-Threonine      48 
  L-Tryptophan      10 
  L-Tyrosine       100 
  L-Valine       46 
  L-Ornithine/HCl      10 
  Adenosine       12 
These amino acids and adenosine were dissolved separatly, mixed together and 
then added to following stock solutions: 
          [ml/l] 
  MEM nonessential amino acids solution  10 
  MEM vitamine solution     10 
This so-called basic medium was sterilized and could be stored at 4°C for up to 
3 months.  
 
Complete culture medium 
For preparation of a complete culture medium the following stock solutions 
were added to the basic medium: 
           [ml/l]  
 NaHCO3   (750mg/10ml distilled water)  30 
 L-Cysteine   (30.3mg/10ml distilled water)  10 
 Bathocuproindi-  (5.6mg/10ml distilled water)  1 
 sulfonate (BCS) 
 Hypoxanthine  (13.6mg/10ml 0.1 N NaOH)  10 
 2'-Desoxythymidine (3.9mg/10ml distilled water)  10 
 L-Glutamine  (292mg/10ml distilled water)  10 
 Sodiumpyruvate  (220mg/10ml distilled water)  10 
 Myristic acid linked on defatted BSA (50 x)   20 
 Fetal calf serum  (heat inactivated: 30min. 56°C) 100 
 Penicillin-Streptomycin-solution     5 
   
Preparation of the myristic acid linked to defatted BSA (Ferguson & Cross, 
1984): 
24 mg myristic acid was dissolved in 100 µl ethanol (95%). This myristic acid 
was then gradually added to a BSA solution (1 g defatted BSA/20ml distilled 
water). The medium was sterilized and stored at 4°C for about 4 weeks. 
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Culture medium for procyclics pH 7.4 
The following stock solutions were added to the basic medium to cultivate of 
procyclic parasites: 
 
           [ml/l] 
 Glutamine   (5.6mg/10ml distilled water)  10 
 Haemin   (25mg/10ml distilled water)  3 
 Pyruvate   (220mg/10ml distilled water)  10 
 Proline   (600mg/10ml distilled water)  10 
 Fetal calf serum    (heat inactivated: 30min. 56°C) 100 
 Penicillin-Streptomycin-solution     5 
 The culture medium was sterilized and stored at 4°C for up to 4 weeks. 
 
 
Tunicamycin stock solution 
  250 µg/ml in H2O ( 25x ) 
 
   
2.2.2 Lysates Preparation from T. brucei for Cell-Free Translation  
 
Protease inhibitor mix (1000 x) 
  Pepstatin       1 mM 
  Chymostatin      1 mM 
  Leupeotin       1 mM 
The 3 inhibitors were dissolved in DMSO and stored as aliquots at -20°C. 
 
2-Aminopurin stock solution 
  2-Aminopurin      500 mM 
dissolved in DMSO. 
 
Lysis medium 
  DTT        2 mM 
  Protease inhibitors mix     1 µM 
  2-Aminopurin      10 mM 
 
Phosphate buffer (PB), pH 7.4 (10 x) 
  Na2HPO4       138.2 mM 
  KH2PO4       42.7 mM 
 
__  24 ____________________________________________  Materials and Methods __ 
 
 
2.2.3 RNA Isolation from Trypanosomes 
 
Chloroform/isoamylethanol      24:1 
 
TM-Buffer, pH 8.6 
Tris/HCl       50 mM 
MgCl2       5 mM 
 
TE-Buffer, pH 7.5 
  Tris/HCl       10 mM 
  EDTA       1 mM 
 
DNase-Buffer, pH 7.5 
Tris/HCl       40 mM 
MgCl2       6 mM 
 
 
2.2.4 In vitro Translation 
 
Multi supplement 
  Amino acids without methionine    each 1 mM 
  DTT        21.8 mM 
  Spermidine chloride     2.1 mM 
  Peotease inhibitors     each 10 µM 
  MgCl2       21.3 mM 
  KAc        1.7 mM 
Stored at -70°C. 
 
Creatinkinase solution 
  Creatinkinase      200U/ml 
  KCl        100 mM 
  HEPES-KOH, pH 7.4     20 mM 
  Glycerol       50 % (v/v) 
Stored at -20°C. 
 
Standard supplement mix 
  Multisupplement  (stock solution, -70°C)  94 µl 
  Creatinkinase solution (stock solution, -20°C) 20 µl 
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  1 M Creatinphophate     10 µl 
  10 mM GTP (stock solution, -70°C)   15 µl  
  100 mM ATP      10 µl 
Prepared immediately before each use. 
 
L-[35S]-methionine in vitro translation mix 
  Supplement mix without methionine   6 µl 
  Lysate       20 µl 
  [35S]-methionine      300 kBq 
  Distilled water      ad 40 µl 
    
Biotin in vitro translation mix 
  Supplement mix (without amino acids)  6 µl 
  Amino acids without lysine    1.25 nmol 
  Lysate       20 µl  
  Biotin-lys-tRNA      10 pmol 
  Distilled water      ad 40 µl                                    
   
 
2.2.5 SDS-PAGE According to Laemmli 
 
Running gel (2.6% C)     (10% T)  (12% T) 
  Rotiphorese gel 30   15.2 ml 18.24 
  1 M Tris-HCl pH 8.8   17.2 ml 17.2  
  Distilled water    13.2 ml 10.16 
  10% SDS     456 µl 456 µl 
  10% Ammonium peroxodisulfat 156 µl 156 µl 
  TEMED     48 µl  48 µl 
 
Stacking gel 
  Rotiphorese Gel 30     4.0 ml 
  1 M Tris-HCl pH 6.8     3.0 ml 
  Distilled water      16.8 ml 
  10% SDS       240 µl 
  10% Ammonium peroxodisulfat   120 µl 
  TEMED       24 µl 
 
Sample buffer (2 x) 
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  Tris-HCl pH 6.8      180 mM 
  SDS        4.4 % 
  Glycerol       19.4 % 
 
DTT/BPB (20 x) 
  DTT        1 M 
  Bromophenolblue      0.2 % 
 
Running buffer 
  Tris/HCl       25 mM 
  Glycine       192 mM 





  Coomassie Brilliant Blue R    0.1 % 
  Methanol       40 % (v/v) 
  Acetic acid       10 % (v/v) 
 
Destaining solution 
  Acetic acid       10 % (v/v) 





  Acetic acid       24 ml 
  Ethanol       80 ml 
  Formaldehyde 37 %     100 µl 
  Distilled water      ad 200 ml 
 
Wash solution 
  Ethanol       50 % 
 
Incubation solution 
  10 % Na2S2CO3      400 µl 
Distilled water      ad 200 ml 
 
 




  Silver nitrate      0.4 g 
Formaldehyde (37 %)     150 µl 
Distilled water      ad 200 ml 
 
Developing solution 
  Na2CO3       18 g 
  10 % Na2S2CO3      12 µl 
  Formaldehyde (37 %)     150 µl 
  Distilled water      ad 300 ml 
 
Stop solution 
  Acetic acid       24 ml 
  Ethanol       80 ml 
  Distilled water      ad 200 ml 
 
Gel drying solution 
  Ethanol       25 % (v/v) 





Transfer buffer, pH 9.2 (Bjerrum & Schafer-Nielsen, 1986) 
  Tris/HCl       48 mM 
  Glycine       39 mM 
  SDS        0.00375 % 
  Methanol       20 % 
 
Blocking buffer 
  Defatted milk power in PBST    10 % 
 
PBS 
  Na2HPO4       80 mM 
  NaH2PO4       20 mM 
  NaCl        100 mM 
 





  Tween 20 in PBS      0.1 % 
 
Stripping buffer, pH 6.7 
  2-mercaptoethanol     100 mM 
  SDS        2 % 
  Tris-HCl       62.5 mM 
 
 
2.2.7 Deglycosylation Using N-Glycosidase F  
 
Deglycosylation buffer, pH 7.5 
  Na2HPO4/NaH2PO4     250 mM 
  EDTA       10 mM 
  N-Octylglucosid      1.4 % 
  β-Mercaptoethanol     1 mM 
  NaN3        0.05 % 
  Protease inhibitors     1 µM each 
 
 
2.2.8 Bacterial Media 
 
LB-medium, pH 7.0 
  Peptone       1 % 
  Yeast extract      0.5 % 
  NaCl        0.5 % 
Adjusted to pH 7.0 using 1 M NaOH. 
 
Ampicillin stock solution (1000 x) 
  Ampicillin in 70 % ethanol    50 mg/ml 
 
Culture plate 
  Agar-Agar in LB medium    1.5 % 
 
Transformation medium for E.coli (TSS-Buffer) 
  DMSO       5 % 
  MgCl2       50 mM 
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  PEG6000       10 % 
made from LB medium. 
 
 
2.2.9 Molecular Biology 
 
DNA sample buffer, pH 8.0 
  Glycerol       5 % 
  Bromophenol blue     0.025 % 
  EDTA       0.1 M 
 
TAE-buffer, pH 8.0 
  Tris-HCl       0.04 M 
  EDTA       0.001 M 
Adjusted to pH 8.0 with acetic acid. 
 
 




Column buffer and lysis buffer, pH 7.4 
  Tris-HCl       20 mM 
  NaCl        200 mM 
  EDTA       1 mM 
 
Elution buffer 
  Maltose in column buffer    10 mM 
 
Incubation buffer for enterokinase, pH 8.0 




Lysis buffer, pH 8.0 
  HEPES       20 mM 
  NaCl        500 mM 
 EDTA       1 mM 
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  Triton X-100      0.1 % 
Column buffer, pH 8.0 
  HEPES       20 mM 
  NaCl        500 mM 
  EDTA       1 mM 
 
Cleavage buffer, pH 8.0 
  HEPES       20 mM 
  NaCl        500 mM 
  EDTA       1 mM 
  DTT        50 mM 
 
Stripping buffer, pH 8.0 
  HEPES       20 mM 
  NaCl        500 mM 
  SDS        1 % 
 
6xHis Tag System  
 
For Native Conditions 
 
Lysis buffer, pH 8.0 
  NaH2PO4       50 mM 
  NaCl        300 mM 
  Imidazole       10 mM 
 
Wash buffer, pH 8.0 
  NaH2PO4       50 mM 
  NaCl        300 mM 
  Imidazole       20 mM 
 
Elution buffer, pH 8.0 
  NaH2PO4       50 mM 
  NaCl        300 mM 
  Imidazole       250 mM 
 
For Denaturing Conditions 
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Lysis buffer, pH 8.0 
  NaH2PO4       100 mM 
  Tris-HCl       10 mM 
  Urea        8 M 
Wash buffer, pH 6.3 
  NaH2PO4       100 mM 
  Tris-HCl       10 mM 
  Urea        8 M 
 
Elution buffer, pH 4.5 
  NaH2PO4       100 mM 
  Tris-HCl       10 mM 
  Urea        8 M 
 
 
2.2.11 Detection of the Transamidase Activity of Trypanosomal Lysate and 
Cloned TbGpi8 Using Fluorogenic Peptide Substrate 
 
Detection buffer, pH 6.5   
  Hepes       50 mM 
  NP40        0.1% 
  Protein inhibitors      1 µM each 
 
 
2.2.12 Production of Antibodies 
 
Immunization emulsion C 
  MBP-Gpi8       0.5 mg 
  PBS        500 µl 
  Freunds complete adjuvant    500 µl 
 
Immunization emulsion I 
  MBP-Gpi8       0.5 mg 
  PBS        500 µl 
  Freunds incomplete adjuvant    500 µl 
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2.2.13 Isolation and Affinity Purification of Special Antibodies 
 
Phosphate buffer, pH 7.2 
  Na2HPO4       1.8 g/l 
  KH2PO4       1.4 g/l 
  NaCl        5.8 g/l 
 
PEG 6000 
  PEG 6000 in phosphate buffer    7 %, 24 %  
          and 50 % 
          
Elution buffer pH 2.5 
  Glycine/HCl      100 mM 




Hank's buffered saline (HBS) pH 7.3 
  NaCl        0.85 % 
  HEPES       25 mM 
   
FHBS 
  Formaldehyde in HBS     1 % 
 
 
2.2.15 Electron Microscopy 
 
EM-buffer, pH 7.4 (Glaubert, 1975; Langreth & Balber, 1975) 
  Sodium cacodylate x 3 H2O    0.1 M 
  Sucrose       0.12 M 
 
Glutaraldehyde solution (Glaubert, 1975) 
  Glutaraldehyde in EM-buffer    2 % 
 
Uranyl acetate solution 
   Uranyl acetate in distilled water   5 % 
Stored at RT in the dark. 
 
 




  Osmiumtetroxide in distilled water   3 % 
 
Epon-Mix (Luft, 1961) 
  Epon 812       16.8 g 
  DDSA       8.0 g 
  MNA        8.7 g 
  DMP-30       0.3 g 
Should be prepared immediately before use. 




Precipitation buffer, pH7.8 
  Tris-HCl       50 mM 
  NaCl        150 mM 
  NP-40       1 % 
  Sodium azide      0.025 % 
  Protein inhibitors      1 µl each 






2.3.1 General Methods 
 
2.3.1.1 SDS-PAGE According to Laemmli 
 
SDS-PAGE was accomplished in Mighty Small II SE 250 gel chambers 
according to the method of Laemmli (Laemmli, 1970) with 4 % stacking gel and 
10% or 12 % running gel. For determination of the molecular mass scale 
suitable molecular markers were used.  
 
2.3.1.2 Commassie Staining 
 
Following electrophoresis, the gel was stained in 1 mg/ml Commassie blue R for 
at least 1 h. The gel was destained in destaining solution for about 2 h. 
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2.3.1.3 Silver Staining 
 
The gel was fixed in fixative for 10 min and washed with ethanol (50 %) 3 times 
for 10 min each. After incubated 1 min in incubation buffer, the gel was washed 
with water 3 times for 20 sec. The gel was then incubated in silver stain solution 
for 20 min and washed 2 min with water. Thereafter the gel was soaked in 
developing solution until bands appeared. The gel was treated with stop solution 
and washed with 50 % ethanol. 
 
2.3.1.4 Fluorography  
 
After Coomassie- or Silver staining, the gel was incubated in AmplifyTM for 15-
30 min. The dried gel was exposed to Biomax MR (Kodak) film at -70°C. The 
film then was developed and fixed. The exposure time varied according to the 
intensity of radioactivity between 2 days and 1 week. 
 
2.3.1.5 Western Blotting Analysis 
 
Western blotting was performed using a Semi-Dry-Apparatus. Three filter 
papers were laid on the anode plate. Then nitrocellulose membrane, gel and 3 
filter papers were added one after another. All the materials were soaked with 
transfer buffer before use. The electro transfer was carried out by a constant 
electric current of 5.5 mA/cm2 for 30 min. 
 
2.3.1.6 Immunofluoroscopy of Cells  
 
1 x 107 trypanosomes were fixed in 1 ml FHBS for at least 1 h. After two times 
washing with cold HBS and two times washing with cold 1 % BSA cells were 
resuspended in 400 ul 1 % BSA. 5 µl of this suspension was transferred to glass 
slides and dried at 37°C for 3 h or at RT overnight. The slide with fixed cells 
was incubated 15 min with 10 µl first antibody in a wet box and washed 5 min 
with distilled water and dried at RT. It was then incubated 15 min with FITC 
labelled second antibody and washed again for 5 min. The slide was then 
incubated in bisbenzimid for 15 min and again dried at RT. The photography 
document was viewed and analyzed using an Olympus BH2 fluororesent 
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2.3.1.7 Electron Microscopy of Cells 
 
Fixation 
1 x 108 trypanosomes were fixed in 2% glutaraldehyde in EM-buffer at 4°C for 
60 min (Langreth & Balber, 1975; Glauert, 1975). The cells were washed two 
times with EM buffer for 5 min and stained with 1.5% osmium tetroxide at 4°C 
for 60 min. The cells were washed two times with EM buffer and two times with 
distilled water (5 min each). For additional staining, the cells were incubated 
with 0.5% uranyl acetate at RT for 60 min and washed with distilled water. The 
fixed cells were dehydrated using ethanol solutions of increasing concentrations 
(30%, 50%, 70%, 95%, 100%, 100%, 1 h each at RT) and washed two times 10 
min each with propylenoxide. 
 
Embedding 
The sample was incubated with Epon:propylenoxide (1:1, 60 min, RT), 
infiltrated with pure Epon (60 min, RT) and transferred to BeemR-Cups. The 
polymerization was carried out for 12 h at 45°C and 36 h at 60°C. 
 
Ultra sectioning 
After polymerization the tip of the sample was trimmed to trapezoidal shape on 
Primetime 11800, sectioned using an Ultra tome and fished with copper grits.  
 
Immunogold labeling 
The grit was washed 3 times with 20 mM Glycine/PBS and incubated with 10 µl 
of the first antibody (1:100) (60 min, RT). After 3 times washing with 0.1% 
BSA/PBS the sample was incubated with 10 µl of second antibody for 60 min. 




The grit was contrasted on a 50 µl 5% uranyl acetate drop (60 min, RT, face 
down) (Lewis & Knight, 1977). The grit was washed with distilled water and 
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The sample was viewed and photographed on Zeiss EM 109 transmission 
electron microscope with TFP-camera using negative film Kodak Plus-X-Plan 
120 (125 ASA, 60 x 70 mm). 
 
 
2.3.2 In vitro Translation System  
 
2.3.2.1 Cultivation and Isolation of Trypanosomes from Rat  
 
 Long slender bloodstream forms of T. b. brucei were grown in rats. Rats were 
injected with 2-4 x 107 trypanosomes intraperitoneally in a volume of about 500 
µl. After 2.5 days, trypanosomes grew to about 0.5-1 x 109 cells/ml. Normally 
they have 6 hours generation time. If the cell concentration was above 5 x 
108/ml, the rats were killed with CO2. The blood was collected in the thorax by 
cutting the Vena cava inferior. Some CGA (~1 ml) was given to the thoracic 
cavity and the centrifuge tube to prevent blood coagulation. Infected blood was 
centrifuged at 1,300 g for 10 min at 4°C and the buffy coat, which contained the 
trypanosomes, was resuspended in separation buffer. The buffy coat was applied 
to a column with about 70 ml DEAE-cellulose and washed with separation 
buffer immediately. The flow-through containing the trypanosomes was 
collected and spun again as before.  
 
2.3.2.2 Lysis of Trypanosomes 
 
The freshly isolated trypanosomes were lysed in cold lysis buffer at a cell 
density of 7x109/ml and immediately homogenized with a Dounce-
Homogenisator.  The cell lysis was controlled by phase microscopy. After cell 
lysis 1/9 volume phosphate buffer (PB, 10x) was added to the lysate. The lysate 
was centrifuged at 12,000 g for 6 min at 4°C to remove cell debris and the 
supernatant was immediately aliquot and stored in liquid nitrogen. 
 
2.3.2.3 In vitro Translation Using Trypanosomal Lysates 
 
The cell free system was prepared from trypanosomal lysates (final 
concentration 50%, v/v) that was supplemented with standard supplement mix, 
distilled water and [35S]-methionine or biotin-lys-tRNAlys and UDP-[14C]-
galactose. The translation mix contained: 
 
 
__  Materials and Methods ____________________________________________ 37 __ 
 
 
Cell lysate   PMS (postmitochondr. supernatant) 50 % (v/v) 
 
Amino acids  19 proteinogenic amino acids  100 uM 
without Methionine or  
lysine respectively 
 
Labelled substrate  [35S]-methionine    7.5 kBq/µl 
    or biotin-lys-tRNAlys   0.25 pmol/µl 
    UDP-[14C]-galactose   46 Bq/µl 
 
Energy regenerating ATP      1.0 mM 
system   GTP      150 µM 
    Creatine phosphate   10 mM 
    Creatine kinase    4 U/ml 
 
Buffer   Na2HPO4     6.9 mM 
    KH2PO4     2.1 mM 
    HEPES     403 µM 
 
Electrolyte   KAc      161 mM 
    KCl      2 mM 
    MgCl2     2 mM 
 
Polyamine   Spermidinchlorid    200 µM 
 
Protectors and  DTT      3.0 mM 
Inhibitors   2-Mercaptoethanol   0.2-0.8 mM 
    Pepstatin A, chymostatin, leupeptin each 1 µM 
    2-Aminopurin    4.5 mM 
    ZnCl21     0.2 mM 
 
Other components2 Glycerin     1 % (v/v) 
    DMSO     1 % (v/v) 
Kalium-pyridin-3,4-dicaboxylate 0.3-0.8 mM  
 
1 Used to inhibit GPI-PLC. 
2 These components were added from stock solutions. 
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The mix was incubated at 30°C for 60 min and cooled on ice thereafter to stop 
the reaction. 
 
2.3.2.4 LSC Quantification of the Radioactive Incorporation 
  
After in vitro translation 450 µl 1 N NaOH and 50 µl H2O2 were added to 5 µl 
lysate sample and incubated at 37°C for 30 min. Thereby tRNA linked [35S]-
methionine was released and would not be co-precipitated with protein in the 
next step. For precipitation of the protein 20 µl 1 % BSA and 1.5 ml 25 % TCA 
were added prior to the incubation on ice water for at least 6 hours or over night. 
Glass fibre filter GF/C was placed on a filtration apparatus and was socked in 8 
% TCA. The precipitated material was resuspended with a plastic pipette and 
transferred onto the filter. The filter was then washed with 2.5 ml 8 % TCA. 
Additionally each filter was washed 3 times with 8 % TCA and 1 time with 
ethanol. The filter was dried by air pumping 1-3 min. The activity on the filter 
was measured in scintillations-cocktail Ultima GoldTM by liquid scintillation 
counting (LSC). 
 
2.3.2.5 N-Glycosidase F Treatment after in vitro Translation  
 
SDS was added to the translation products to give a 2 % concentration. The 
samples were boiled for 5 min and cooled on ice. 20 µl of this material was 
added to 170 µl incubation buffer (see 2.1.9.6) and again boiled for 5 min. After 
cooling the probes to 37°C, 2 U N-glycosidase F was added and incubated at 37 
°C for 20 hours. After incubation, the sample was diluted to 1 ml and mixed 
with 5 µl cytochrome C and 8 µl sodium desoxycholate and incubated at room 
temperature for 15 min. After mixing with 100 µl TCA (67 %) the sample was 
centrifuged at 10,000 g for 30 min at 4°C. The pellet was treated with 20 µl 
SDS-PAGE loading buffer and 8 % NH4OH was added until the color changed 
from orange to blue. 
 
2.3.2.6 Capture of Biotinylated Translation Products 
 
60 µl translation mix was diluted in 0.5 ml of PBS-Tween. 100 µl of avidin 
agarose were added to the mix and the reaction tube was incubated by end-over-
end rotation at 4°C for 1 h. After 3 washing cycles (5 min each in 1 ml of PBS-
Tween on a rotary mixer at 4°C, followed by a 1 min centrifugation in a 
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microfuge) the pellet was resuspended in 40 µl of SDS-PAGE loading buffer. 
The biotinylated proteins were eluted by heating the tube to 100°C for 4 min. 
 
2.3.2.7 Detection and Characterization of the Biotinylated Translation 
Products 
 
After electrophoresis, the proteins were blotted onto a nitrocellulose membrane. 
The membranes were probed with streptavidin-horseradish peroxidase for 
detection of the newly formed protein, with clone-specific antibodies for 
detection of VSG or with antibody specific for the CRD for detection of the GPI 
anchor respectively. The results were visualized with ECLTM detection reagents 
and by fluorography.     
 
 
2.3.3 In vitro Cultivation of Trypanosomes 
 
2.3.3.1 Cultivation of Bloodstream Form Trypanosomes in vitro 
  
Cells were cultivated at 37°C in a water saturated atmosphere containing 5 % 
CO2. The medium was incubated at 37°C before used. Cells were harvested at a 
density of about 1-2 x 106/ml. For glycosylation inhibition and anchor exchange 
either 10 µg/ml tunicamycin and/or 0.5 mM hydrazine was added to the culture 
medium. 
 
2.3.3.2 Cultivation of Procyclic Form Trypanosomes in vitro 
 
The cells were cultivated at 27°C with medium in an incubator without CO2. 
Cells harvested at a density of about 2 x 106/ml. 
 
 
2.3.4 Cloning  
 
2.3.4.1 PCR  
 
Standard-PCR using Taq-polymerase 
PCR reactions were performed in 50 µl reaction mixture containing 50 ng 
template DNA, 5 pM of each primer, 0.2 mM dNTPs and 2.5 units Taq-DNA 
polymerase in PCR Taq-polymerase buffer. The reaction was cycled though the 
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following temperature profile, preceded by an unique 3 min denaturation step at 
94°C: 
 
Denaturation  1 min, 94°C 
Annealing   1 min, 45°C 
DNA synthesis  1 min, 72°C 
No of cycles  30 
 
Control-PCR using Taq-polymerase 
These PCR reactions were also performed in a volume of 50 µl containing 5 pM 
of each primer, 0.2 mM dNTPs in Taq-polymerase buffer and 2.5 units Taq-
DNA polymerase. The templates were either plasmids from mini-preparation 
(1:1000 diluted) or cultured cells alone. The reaction was cycled though the 
following temperature profile: 
 
Denaturation  1 min, 94°C 
Annealing   45 sec, 38°C 
DNA synthesis  1 min, 72°C 
No of cycles   30 
 
PCR-using proof reading polymerase 
PCR reactions were performed in 50 µl reaction mixture containing 50 ng 
template DNA, 5 pM of each primer, 0.2 mM dNTPs and 1.25 units Pfu-DNA 
polymerase in PCR Pfu-polymerase buffer. PCR Pfu-polymerase should be the 
last component added to the PCR mixture. The PCR-mixture was prepared at 
4°C. The reaction was cycled though the following temperature profile: 
 
Denaturation  1 min, 94°C 
Annealing   1 min, 45°C 
DNA synthesis  2 min, 72°C 
No of cycles   30 
 
2.3.4.2 Agarose Gel Electrophoresis 
 
The DNA fragments were separated in submersed horizontal agarose gels 
(0.8%) with 0.5 µg/ml ethidium bromide. The samples were mixed with loading 
solution and were electrophoresed along with size markers. The electrophoresis 
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was carried out in TAE buffer at 60-100 kV for 30 min and DNA was visualized 
under UV light.  
 
2.3.4.3 Elution of DNA from Agarose Gel 
 
The ethidium bromide stained agarose gels were inspected under UV light and 
the part of the gel that contained the desired DNA fragment was excised out 
using a clean sharp scalpel. The gel slice was transferred to a 1.5 ml microfuge 
tube and buffer 1 of kit (agarose gel elution kit) was added to dissolved agarose 
and incubated at 50°C for 5 min. After complete solubilization of agarose, 10 µl 
of the resuspended solution 2 was added and incubated at 50°C for 10 min by 
mixing the reaction vial every 2 min. The silica particles were precipitated by a 
brief centrifugation (30 sec.) and the supernatant was removed carefully. The 
pellet was resuspended in 500 µl buffer 3 by vortexing and then recentrifuged. 
Then pellet was air-dried for 10-15 min until it turned to white. The DNA was 
eluted by resuspending the pellet in 20 µl 10 mM Tris-HCl, pH 7.5 and 
subsequent incubation at RT for 5 min. The elute was separated from the silica 
gel by centrifugation and was transferred to a fresh vial. 
 
2.3.4.4 Isolation of Plasmid from Bacteria (Minipreparation) 
 
1 ml overnight grown bacterial cultures were concentrated by centrifugation 
(13,000 g, 30 sec) in Eppendorf tubes. Cells were resuspended in 150 µl TGE 
(pH8.0) and lysed by addition of 300 µl lysis solution (200 mM NaOH, 1% 
SDS, freshly prepared) and incubated for 2 min at RT. Thereafter 450 µl chilled 
KAc (5M, pH 4.8) was added and mixed carefully. After 5 min incubation on 
ice, the cloudy and viscous solution was centrifuged (10 min, 13,000 g) and the 
supernatant was collected. This processure was repeated one time again. The 
collected supernatants were mixed with isopropanol (0.7-1 x v), vortexed and 
centrifuged (13,000g, 15 min, 4°C). The supernatant was discarded and the 
pellet was washed with 70% ethanol (-20°C). The pellet was then dissolved in 
50 µl Tris-HCl (pH 7.5) containing 10 µg/ml RNase A. 
 
2.3.4.5 Restriction Digestion of DNA 
 
Plasmid DNA and PCR products were digested with endonucleases and checked 
by gel electrophoresis. Approximately 100 ng - 3 µg DNA in 20-50 µl was 
incubated with endonucleases for 1-2 h at 37°C using producer's buffer 
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according to the manufacturer’s instruction. The RNA in Plasmid DNA solution 
from minipreparation was removed by incubation with 1/20 vol RNAase A 




The restriction digested PCR products and plasmids were prepared for ligation 
by phosphorylation and dephosphorylation using T4 polynucleotide kinase and 
calf intestine alkaline phosphatase (CIP). The T4 DNA ligase and ligase buffers 
were added according to the instruction of the producers. Vector and insert DNA 
were used in the ratio of 1 to 2.5. 
 
2.3.4.7 Preparation of Competent Bacterial Cells 
 
A single colony of E. coli (strains XL1-Blue or ER2668) was grown at 37°C in 
LB medium until the OD600 reached about 0.5. Cells was harvested by 
centrifugation (5,000 g, 10 min, 4°C) and resuspended in 10 ml (1/10 vol.) ice-
cold TSS-buffer by gentle shaking (5% DMSO, 50 mM MgCl2, 10 % PEG6000) 
(Chung et al., 1989). The competent cells were aliquoted (100 µl) shock frozen 
in liquid nitrogen and stored at -80°C until used for transformation with 




5-10 µl of the ligated vector was pipetted to an ice-cold test tube before 100 µl 
of competent E. coli cells were added using chilled blue tips. After 10 min 
incubation on ice and 2 min incubation at 37°C the cells were chilled in an ice 
bath for 2 min. The transformed competent cells were plated on LB-agar plates 
containing Ampicillin (50 µg/ml). The plates were incubated over night at 37°C. 
 
 
2.3.5 Heterologous Expression and Purification of Recombinant Protein 
 
2.3.5.1 Induction of the Bacteria Strain ER2566 
 
The cells were grown at 37°C in LB medium containing 100 µg/ml ampicillin. 
When the OD600 of the culture reached 0.5-0.8, protein expression was induced 
at 15°C over night with IPTG at a final concentration of 0.3 mM. The cells from 
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the above culture were spun down at 5,000 g for 10 min at 4°C. After discarding 
the supernatant the cell pellet was stored at -20°C.  
 
2.3.5.2 Preparation of Crude Cell Extract 
 
The cell pellet from a 50 ml culture was resuspended in 5 ml ice-cold cell lysis 
buffer. The cells were broken by sonication in short pulses of 15 sec for 15 min 
in ice water. The clarified cell extract was obtained by centrifugation at 12,000 g 
for 30 min. 
 
2.3.5.3 Purification of the Protein 
 
Intein-tagged protein 
Chitin beads were equilibrated at 4°C with 10 volumes of the column buffer 
prior to the loading of the crude cell extract. The clarified extract was slowly 
loaded onto the chitin column, which was washed with about 10 bed volumes of 
the column buffer. The on-column cleavage was conducted by quickly flushing 
the column with 3 bed volumes of the cleavage buffer containing 50 mM DTT. 
After a quick flush the flow in the column was stopped, and the column left at 4-




One ml of 50 % Ni-NTA slurry was added to 5 ml cleared lysate and mixed 
gently by shaking at 4°C for 60 min. The lysate-Ni-NTA mixture was loaded 
into a column with the bottom outlet capped. The column was washed with 4 ml 
wash buffer. The protein was eluted 4 times with 0.5 ml elution buffer. 
 
Maltose-binding protein-tagged protein 
Two ml amylose resin suspension was poured to a column and washed with 16 
ml column buffer. 5 ml cleared lysate was loaded onto the column and washed 
with 24 ml column buffer. The fusion protein was eluted with column buffer 
containing 10 mM maltose. The elute was dialyzed against 50 mM Tris-HCl (pH 
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2.3.6 Production of Antibodies Against TbGpi8 
 
2.3.6.1 Immunization of Chicken with TbGpi8 
 
The chicken was immunized with isolated MBP-TbGpi8. After the first 
immunization with emulsion C the chicken was immunized two times with 
emulsion I again at the 28th and 42nd day successively. 
 
2.3.6.2 Isolation of the Chicken Antibodies 
 
Three egg yolks were carefully separated from egg whites, mixed with 25 ml 
phosphate buffer and 75 ml PEG (7 %) and incubated at 4°C for 30 min. After 
centrifugation at 3000 g for 10 min at 4°C the supernatant was filtered through a 
mull. PEG was added to the filtrate to a final concentration of 12 % and 
incubated at 4°C for 30 min. After centrifugation at 3000 g for 10 min at 4°C, 
the pellet was resuspended in 50 ml phosphate buffer and 50 ml 24 % PEG and 
incubated at 4°C for 30 min. The mixture was centrifuged at 3000 g for 10 min 
at 4°C, followed by resuspension of the pellet in 25 ml phosphate buffer and 25 
ml ethanol. After centrifugation at 3000 g for 10 min at 4°C the pellet was 
dissolved in 10 ml phosphate buffer and centrifuged at 3000 g for 10 min at 4°C 
again. The supernatant was stored at -20°C. 
 
2.3.6.3 Affinity Purification of Chicken Anti-TbGpi8 Antibodies 
 
10 ml isolated chicken antibodies were subjected to a 1 ml amylose column 
containing only MBP. The flow through without antibody against MBP was 
pooled and put onto a second 1 ml amylose column containing the fusion protein 
MBP-TbGpi8. The column was washed with phosphate buffer thoroughly. In 
this course, specific antibody against TbGpi8 was bound on the column and was 
eluted with elution buffer (pH 2.5) thereafter. 
 
2.3.6.4 ELISA of Chicken Anti-TbGpi8 Antibodies 
 
The 96 well micro plate was incubated with 100 ng MBP-TbGpi8/100 µl coating 
buffer at 4°C overnight and washed 2 times with 200 µl wash buffer. After 
incubation with 100 µl blocking buffer at RT for 30 min, it was incubated with 
100 µl serially diluted anti-TbGpi8 antibody at RT for 1 h, followed by a 2 times 
wash with 200 µl wash buffer. Each well of the micro plate was then incubated 
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with 100 µl IgY/POD (1:5,000) at RT for 1 h. After 2 times washing 100 µl 
substrate solution was added and incubated at RT for 30 min in the dark. After 




2.3.7 Characterization of TbGpi8    
 
2.3.7.1 In vitro Test of the Anchor Exchange Activity  
 
Intein-tagged GFP-VSG221-C-terminus and fluorogenic peptide substrates Ac-
S-V-L-N-AMC were used as substrate for this reaction. The enzyme sources 
were trypanosomal lysates (as control), E. coli lysates or enterokinase treated 
MBP-TbGpi8 or 6xHis-tagged TbGpi8. The cell lysates or enterokinase treated 
MBP-TbGpi8 or 6xHis-tagged TbGpi8 were mixed with GFP-VSG221-C-
Terminus or Ac-S-V-L-N-AMC and 10 mM hydrazine. The mixture was 
incubated at 30°C for 1 h or overnight and analysed by SDS-PAGE, Western 
blotting or spectrofluorimeter. 
 
2.3.7.2 Immunolocalization of TbGpi8  
 
The localization of TbGpi8 was detected using immunofluoroscopy using 
affinity purified chicken anti-TbGpi8 antibodies. FITC conjugated anti-chicken 
IgG was used as second antibody. 
 
2.3.7.3 Western Blotting Analysis of TbGpi8 in Trypanosomal Lysates 
 
Cell lysates from bloodstream form cells were separated through SDS/PAGE. 
Affinity purified chicken anti-TbGpi8 antibodies were used as first antibody and 
















3.1 In vitro Translation  
 
 
3.1.1 Endogenous Translation   
 
Since 1988, cell-free systems from trypanosome bloodstream form have been 
investigated to link translation and different modification of VSG in our 
laboratory. By conventional production of cell lysates, a translation inhibitor 
becomes active, which can only be removed by dialysis, ultracentrifugation with 
a sucrose gradient or gel filtration. Hence, an in vitro translation system from 
trypanosomes without this inhibitor was developed in our laboratory to study the 
post-translational modification of VSG.  
 








Fig. 3.1: Fluorographies of in vitro 
Translated Proteins from Trypanosomal 
Lysates 
 
In vitro translation assays were performed in 
trypanosomal lysates, which were not treated 
(lane1) or treated (lane 2) with Ca2+-dependent 
nuclease S7. The nuclease S7 treated 
trypanosomal lysate was supplemented with 
isolated trypanosomal RNA at 0.2 µg/µl. Newly 
formed proteins were labeled with [35S]-




To avoid liberation of lysosomal constituents, a ‘limited lysis’ was applied to the 
preparation of translational active lysates. Trypanosomes were hypotonically 
lysed in double-distilled water containing DTT, 2-aminopurine and proteinase 
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inhibitors. The cells were homogenized for 7 min using a tight fitting potter. The 
tonicity was adjusted to nearly isotonic conditions by adding 10 % (v/v) of 
phosphate buffer before the sample was centrifuged (6 min, 12000 g, 4°C) to 
obtain the post-mitochondrial supernatant (PMS). This lysate was very efficient 
for in vitro translation after supplemented with an oxidation protector (DTT), 
energy resources (ATP, GTP and ATP regenerating system), different ions and 
amino acids. An incorporation of about 50,000 dpm/µl lysate was regularly 
obtained. As shown in Fig. 3.1, VSG was the primary translation product. 
Radiolabeled protein bands ranged from 7.3  kDa to 200 kDa (Hömke, 1997). 
However, upon digestion of the lysate with Ca2+-dependent nuclease S7 and 
addition of total RNA from trypanosomes, incorporation of radio labeled amino 
acid was very poor, although different RNAs and different techniques to remove 
endogenous mRNAs were tried and tested. Newly formed proteins could not be 
detected by SDS/PAGE/fluorography (lane 2). Thus, reinitiation does not occur 
in our in vitro translation system. Therefore all the following work was carried 
out with this system using endogenous mRNA. 
 
 
3.1.2 In vitro  Translation Using Reticulocyte Lysates 
 
The reticulocyte lysate system is the most widely used eukaryotic cell-free 
protein synthesizing system because of the high translational activity with 
endogenous or exogenous mRNAs. It is easier to study in vitro modification, if 
the produced protein is different to endogenous proteins from the used cell-free 
system in immunological and chemical characters.  
 





Fig. 3.2: Fluorographies of in vitro Translated 
Proteins from Reticulocyte Lysates 
 
In vitro translation assay was performed in 
reticulocyte lysates (lane 1) or in reticulocyte 
lysates supplemented with trypanosomal lysates 
(lane 2) that was treated with Ca2+-dependent 
nuclease S7. Newly formed proteins were labeled 
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A commercially available reticulocyte lysate was used to reinitiate the 
translation of mRNA from trypanosomes and to test the modification ability of 
the supplemented trypanosomal lysate. Trypanosomal lysates were treated with 
nuclease S7 in the presence of 1 mM Ca2+ for 20 min at room temperature 
before EGTA was used to inactivate the nuclease. The lysate was then mixed 
with reticulocyte lysate. As shown in Fig. 3.2, this mixture did not lead to any 
change of newly formed proteins. Thus post-translational modification could not 




3.1.3 N-Glycosylation of in vitro Translated VSG 
 
To show N-glycosylation of in vitro translation products in our cell-free system, 
the lysate was subjected to N-glycosidase F digestion after translation. This 
enzyme cleaves all types of Asn-linked N-glysidic linkage between asparagine 
and N-acetylglycosamine residues.  
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                                Fig. 3.3: Glycosylation of in vitro Translated VSG 
 
Lysates of clone MITat 1.4 were incubated for 1 h at 30°C. Newly formed proteins were 
labeled with [35S]-methionine. After in vitro translation, VSG was dissolved with n-
octylglucopyranoside and treated with N-glycosidase F as described in materials and 
methods. After SDS/PAGE, newly formed proteins were visualized by fluorography (panel 
b); deglycosylation of VSGs was controlled by concanavalin A blotting (panel a). Lane 1 is 
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As shown in Fig. 3.3b, the newly formed VSG band disappeared and resulted in 
a new band with lower apparent molecular mass, indicating that newly 
synthesized VSG underwent translocation and glycosylation in the cell-free 
system. Concanavalin A is a kind of lectins from Jack Bean, which shows high 
affinity for terminal α-D-mannosyl and α-D-glucosyl residues. Ca2+ and Mn2+ 
ions are required for activity. In this experiment, the lysate of trypanosome 
bloodstream form MITat 1.4 was used, which expresses a VSG of the 
oligomannose-type N-glycan with 3 terminal α-D-mannosyl residues. To further 
test the efficiency of the digestion, concanavalin A was used on the blotting (Fig 
3.3a). All VSGs were efficiently digested to a new band with lower molecular 
weight and with a relative weak staining. This weak staining was due to the 
mannose residues of the core structure of the GPI anchor. Because the 'old' VSG 
runs together with the newly formed VSG, this experiment could not tell if the 
newly formed protein was attached with GPI anchor or not, while N-
glycosylation could be clearly demonstrated. 
 
 
3.1.4 Existence of Pro-VSG 
 
Normally the C-terminus of VSG contains 17~23 amino acids, which is absent 
in mature VSG. This C-terminus is very hydrophobic and probably used as a 
temporary membrane anchor (Duszenko & Seyfang, 1993). About one minute 
after completion of the translation, the pro-VSG is processed to mfVSG by 
replacing the C-terminus with the preformed GPI anchor, which forms an amide 
bond with the C-terminal amino acid of VSG (Bangs et al., 1985; Ferguson et 
al., 1986). After in vitro translation, the samples were detected using antibodies 
against the VSG C-terminus to check for pro-VSG. Fig. 3.4 shows the results of 
Western blotting and corresponding fluorography. In lane 1, a protein band with 
C-terminus is located at about 55 kDa and in lane 2 a corresponding band 
visualized by fluorography is also located at the same position. Therefore, this 
experiment suggests that some pro-VSGs are not changed into mf-VSG 
immediately during the VSG processing course. There was always some VSG 
remained as pro-VSG. In addition, the cell sample not undergoing in vitro 
translation showed also a pro-VSG band (data not show). These results indicate 













Fig. 3.4: Western Blotting and 
Fluorography Analysis of the Pro-VSG 
 
An in vitro translation assay was performed 
with lysate MITat 1.2. Newly formed 
proteins were labeled with [35S]-methionine. 
After SDS/PAGE, proteins were blotted onto 
a nitrocellulose membrane. The pro-VSG 
was detected with anti-C-terminus antibody 
(lane 2); newly formed proteins were 






3.1.5 GPI Anchoring of the VSG Formed during in vitro Translation  
 
3.1.5.1 The Biotin-Lysine System 
 
In vitro translation assays have traditionally been monitored by following the 
incorporation of a radiolabeled amino acid into newly synthesized protein. There 
is an alternative nonradioactive biotin-labeling method. tRNALys is first 
aminoacylated with lysine, which is then chemically labeled with biotin, 
modified in the ε-position of the amino acid. If biotin-lysine-tRNALys is added to 
the in vitro translation system, the biotinylated lysine is incorporated into the 
growing polypeptide chain. Since preexistent proteins always interfere with the 
modification analysis of the newly formed proteins, the biotin-lysine was used in 
an in vitro translation system instead of [35S]-methionine to label newly formed 
proteins to solve this problem. Using this method, newly formed proteins could 
be isolated from the lysate by affinity chromatography using avidin-linked 
agarose. In following tests, Biotin-lysine was efficiently incorporated to newly 
formed proteins. These proteins could be detected by blotting the SDS/PAGE 
gel onto a nitrocellulose membrane and visualized using a strepavidin detetion 
kit. The protein distribution detected by fluorography was similar to those 















Fig. 3.5: Comparison of the in vitro Translation 
Using [35S]-Methionine and Biotin-Lysine-
tRNALys  
 
In vitro translation was performed using MITat 1.4 
lysate. The newly formed proteins were labelled 
with [35S]-methionine (lane 1) or biotin-lysine (lane 
2) respectively in the presence of 7.5 kBq/µl [35S]-





3.1.5.2 Detection of Membrane Anchor Exchange Using Anti-CRD-
Antibodies  
 
The presence of a biotin tag on in vitro translated proteins enables the selective 
capture of biotinylated translation products using immobilized streptavidin. 
Neither translocation across the endoplasmic reticulum nor glycosylation is 
seriously affected by incorporation of the biotin moiety into the protein chain 
(Kurzchalia et al., 1988). It became possible to specifically isolate ‘new’ VSG 
and to detect it on Western blot with specific antibodies. In the cell lysate, the 
highly efficient endogenous GPI-PLC should convert mfVSG to sVSG. This 
enzyme cleaves the phosphodiester bond between phosphate and diacylglycerol 
with the formation of a 1,2-cyclic phosphate ring on the inositol residue, which 
is the primary epitope for anti-CRD antibodies. This cross-reaction is one of the 
main criteria used in the identification of a GPI anchor (Zamze et al., 1988). For 
characterization of the anchor attachment in the newly formed VSG, anti-CRD-
antibodies were used in the following experiments. Due to the presence or 
absence of the cyclic phosphate residue, anti-CRD-antibody specifically reacts 
with the anchor of sVSG, whereas it does not reacted with mfVSG. In our in 
vitro translation system the mfVSG could be rapidly transformed to sVSG with 
high efficiency. The newly formed VSG could also be transformed to sVSG 
immediately after appearance. After the translation mixture was incubated at 
30°C for 1h, it was subject to affinity precipitation using immobilized avidin 
agarose. After SDS/PAGE and blotting, the blot was probed with CRD 
antibodies, VSG antibodies and peroxidase linked streptavdin respectively. As 
 
__  52 ___________________________________________________________  Results __ 
 
 
shown in Fig. 3.6, an avidin-agarose precipitated protein (lane 1) could be 
detected not only with streptavidin and MITat 1.4 VSG-antibodies but also with 
CRD-antibodies, indicating that this protein band is newly formed VSG in our in 
vitro translation system and it is also attached with GPI anchor. The CRD 
antibodies do not react with mfVSG (Panel 2, lane 3), suggesting that the 
antibody is very specific for the GPI anchor in sVSG with CRD epitope, and 
shows no cross reactivity with VSG. These results clearly demonstrate the in 
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                                           Fig. 3.6: GPI Anchor Additon in vitro 
 
During in vitro translation, proteins were labeled with biotinylated lysine and then 
precipitated using immobilized avidin. After SDS/PAGE, proteins were transferred onto a 
nitrocellulose membrane and were detected with clone-specific antibodies (MITat 1.4) for 
VSG (panel a), CRD-specific antibodies for GPI anchor (panel b) and streptavidin-
horseradish peroxidase (panel c) for newly formed VSG. Lane 1 shown the proteins that 
affinity precipitated using avidin-agarose; lane 2 and lane 3 are sVSG and mfVSG used to 





__  Results ___________________________________________________________ 53 __ 
 
 
3.1.5.3 ZnCl2 Inhibition of GPI-PLC 
 
During VSG synthesis, mfVSG should be the first product, which is then 
transformed into sVSG. To identify this process, ZnCl2, a very efficient inhibitor 
of GPI-PLC, was used in in vitro translation. In this experiment the GPI-PLC 
activity was successfully inhibited by addition of 0.2 mM ZnCl2 to obtain 
mfVSG. ZnCl2 at this concentration reduced translation efficiency only 
marginally. Following in vitro translation, samples were centrifuged (100,000 g, 
1 h, 4°C) to separate membrane-bound proteins and soluble proteins. After 
SDS/PAGE and Western blotting, newly formed proteins were detected by 
streptavidin-horseradish peroxidase. As shown in Fig. 3.7, in the absence of 
ZnCl2 (panel a), all VSG was found in the supernatant fraction. Due to the 
endogenous GPI-PLC, mfVSG was readily transformed to sVSG. In the 
presence of ZnCl2 (panel b), about 50% VSG existed in the pellet fraction as 
mfVSG. However, although the amount of mfVSG clearly increased compared 
with the control in the absence of ZnCl2, a total inhibition of the endogenous 
GPI-PLC was not achieved, because 0.2 mM ZnCl2 represents the IC50 for this 
enzyme (Cross, 1984).  
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                                        Fig. 3.7: Effect of Zinc Chloride on GPI-PLC 
 
In vitro translation assay was performed in the presence (panel b) or absence (panel a) of 
ZnCl2. Following in vitro translation, lysates were centrifuged (100,000 g, 1h, 4°C) to 
separate supernatant (lane 1) and pellet (lane 2). After SDS/PAGE, proteins were blotted 
onto a nitrocellulose membrane. Biotinylated proteins have been detected using streptavidin-
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P-chloromercurybenzen-sulfonic acid, other GPI-PLC inhibitor, and higher 
concentration of ZnCl2 inhibited translation distinctly. They could not be used 
for this purpose. Inhibition of the GPI-PLC provided additional evidence for 
GPI anchor exchange in our cell free system. 
 
3.1.5.4 Galactosylation of GPI Anchor in VSG of Clone MITat 1.4 
 
The core structure of GPI anchor is identical in all VSG variants, while the 
galactose side branch varies. VSG of clone MITat 1.4 contains a galactosylated 
GPI anchor, but not a galactosylated oligomannose type N-glycan. After in vitro 
translation, proteins were separated by SDS/PAGE and transferred onto a 
Western blot. The results show a protein band, which was detected with anti-
VSG antibody (Fig. 3.8c). This band was also labelled by biotinylated lysine 
(Fig. 3.8a) and UDP-[14C]galactose (Fig 8b). Since in this clone, galactosylation 
occurs only on the GPI-anchor, the labelling of UDP-[14C]galactose on VSG 
clearly suggests that the in vitro translation system is able to produce GPI 
anchored galactosylated protein. Unlike the L-[35S]-methionine, UDP-
[14C]galactose induced relative poor incorporation of the radioactivity. This is 
might be due to a chase by the existence of endogenous galactose. 
 
 






          
         Fig. 3.8: Double Labelling with Biotinylated Lysine and UDP-[14C]Galactose 
 
Newly formed proteins were labeled in vitro, separated on SDS/PAGE and transferred onto a 
Western blot. The newly formed proteins were double labeled using biotinylated lysine and 
UDP-[14C]-galactose. After SDS/PAGE and Western blotting, the blot was analyzed by using 
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3.2 Investigation of the Anchor Exchange Mechanism in vivo 
 
 
3.2.1 Cell Cultivation in the Presence of Hydrazine  
 
The proposed mechanism of GPI transfer is a transamidation reaction that 
involves the formation of an activated carbonyl intermediate (enzyme-substrate 
complex) with the ethanolamine moiety of the preassembled GPI unit serving as 
a nucleophile. Hydrazine and hydroxylamine are well known to be nucleophilic 
acceptors in the transpeptidase (Tate et al., 1974) and transamidase (Buchanan 
et al., 1973) reactions. They have also been shown to serve as possible 
alternative substrates for GPI using engineered protein miniplacental alkaline 
phosphatase (prominiPLAP) and rough microsomal membranes of HeLa cells. 
The use of readily available nucleophilic substitutes such as Hydrazine and 
hydroxylamine is a viable alternative to study COOH-terminal processing by the 
putative transamidase (Maxwell et al., 1995; Ramalingam et al., 1996). For 
confirmation of the same transamidase mechanism in trypanosomes, hydrazine 
was first used in culture media to determine its toxicity, before it was used to 
investigate its effect on anchor transfer at an appropriate concentration. 
According to the initial experiment, trypanosomes could live in 10 mM 
hydrazine, the normally used concentration in the in vitro anchoring assay, for 
about 5~6 h, but stayed alive for more than 44 h in 0.5 mM hydrazine.  
 
 
3.2.2 Nonglycosylated VSG and Tunicamycin 
 
Tunicamycin inhibits an early step in the formation of asparagine-linked oligo-
saccharides. It is a hydrophobic analogue of the UDP-N-acetylglucosamine 
andblocks the addition of N-acetylglucosamine to dolichophophate, the first step 
to form the core-oligosaccharide. In order to produce a VSG showing a different 
molecular weight as the old VSG, cells were cultivated in the presence of 10 
µg/ml tunicamycin. After 4 h in culture, two VSG bands with a distinctively 
lower molecular weight were successfully produced and could be detected on 
the Western blots with anti-VSG antibodies (Fig. 3.9), glycosylation of VSG 
was efficiently inhibited by tunicamycin. These VSGs are allowed to analysed 
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Fig. 3.9: Western Blotting Analysis of the in vivo 
Synthesized VSGs Using Anti-VSG MITat 1.2 
Antibodies 
 
The cells were cultured in the presence (lane 2) and 
absence (lane 2) of 10 µg/ml tunicamycin. After 4 h 
incubation at 37°C and SDS/PAGE, the proteins were 
transferred onto a nitrocellulose membrane and 





3.2.3 Hydrazine and Hydrazine-Biotin as Substitutes for GPI in 
Transamidation Reaction 
 
Previously, a putative mechanism for the transamidase-mediated nucleophile 
incorporation at the C terminus of protein was proposed (Udenfriend et al., 
1995; Sharma et al., 1999). The carbonyl group of the ω amino acid of pro-VSG 
is activated by a sulfhydryl group in the transamidase resulting in the formation 
of an enzyme-substrate complex and cleavage of the amide bond between ω and 
ω + 1 of pro-VSG. Nucleophilic attack by H2N-X results in formation of VSG-
NH-X and regeneration of the active site sulfhydryl in the transamidase. If 
hydrazine or hydrazine-biotin were used as substitutes for GPI, VSG-NH-NH2 
or VSG-NH-NH-biotin would be produced without GPI anchor and thus could 
not be detected by anti-CRD antibodies. To demonstrate this transamidase 
mechanism, trypanosomes were cultivated in the presence of 10 mM hydrazine 
or 10 mM hydrazine-biotin for 4 h. After SDS/PAGE and Western blotting, the 
same blot was analysed using anti-MITat 1.2 antibodies (Fig. 3.10a), anti-CRD-
antibodies (Fig. 3.10b) and streptavidin-HRP (Fig. 3.10c). If trypanosomes were 
cultivated in the absence of hydrazine and hydrazine-biotin, the produced VSG 
band could be labelled using anti-CRD antibodies (Fig. 3.10, panel b2) while 
cells cultured in the presence of hydrazine or hydrazine-biotin could not be 
detected (Fig. 3.10, panel b3 and b4). This result suggests that the GPI was 
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successfully replaced by hydrazine and hydrazine-biotin. To further prove this 
finding, the blot was additionally tested with streptavidin. Fig. 3.10c shows that 
cells cultured in presence of hydrazine-biotin produced biotin labelled VSG. 
These results show that hydrazine could enter the parasite, function as a 
nucleophile in the transamidation reaction and form a hydrazide derivative of 
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Fig. 3.10: Effects of the Hydrazine and Hydrazine-Biotin in the Anchor Exchange         
Reaction 
 
Trypanosomes were cultivated in the presence of 10 µg/ml tunicamycin (lane 2, 3 and 4) and 
10 mM hydrazine (lane 3) or hydrazine-biotin (lane 4) for 4 h at 37°C. The control samples 
were incubated in the absence of tunicamycin (lane 1) or hydrazine (lane 2). After 
cultivation, the cells were subjected to SDS/PAGE and analysed by western blotting. Anti-
VSG MITat 1.2 antibody and anti-CRD antibody were used to detect VSG (panel a) and GPI 





3.2.4 Immunofluoroscope of the Hydrazine Treated Trypanosomes 
 
Since in cultivated cells hydrazine was incorporated into VSG, this would result 
in the release of a water-soluble derivative of VSG from cell membrane. In 
trypanosomes, VSG intracellular transport and export are critically dependent on 
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the presence of GPI anchor (Bangs et al., 1996 & 1997). This is a common 
feature of GPI-anchored proteins in trypanosomatid protozoa. McDowell et al 
(1998) have investigated the role of GPI-anchor in forward secretory trafficking 
using African trypanosomes. Soluble GPI-minus forms of VSG, in which the C-
terminal GPI-addition peptide signal is deleted, are secreted with a 5-fold 
reduced kinetic. Immunofluorescence localization studies indicate that the GPI-
minus VSG accumulates in the endoplasmic reticulum (ER). Since VSG-
hydrazide is a kind of GPI-minus VSG and should have a similar secretory 






Fig. 3.11: Immunolocalization of 
VSGs before and after Treatment 
with Hydrazine 
 
Cells were cultured in the presence 
(panel b) or absence of hydrazine 
(panel a). After 44 h of incubation 
at 37°C, the parasites were fixed in 
HBS buffer containing 1% 
formaldehyde. VSG was localized 






To determine the location of VSG-hydrazid, immunofluorescence assays were 
performed using cultivated bloodstream form MITat 1.2 cell line. Fixed cells 
were stained with antibodies against MITat 1.2 VSG. The cell nucleus and 
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kinetoplast were stained with bisbenzimid. As shown in Fig. 3.11, VSG was 
equally distributed on the cell surface and stained no obvious visible vesicle 
within the cell, if the cells were not treated with hydrazine (panel a). In contrast, 
in the hydrazine treated cells (panel b) there were a few intensive stained 
vesicles, which located between cell nucleus and kinetoplast. On the cell 
surface, relatively little fluorescence was produced. These results are readily 
explained that hydrazine as a substitute of GPI incorporated into VSG resulting 
in produce of soluble GPI-minus VSG --- VSG hydrazid. VSG hydrazid could 
not be transported to the cell surface leading to accumulation of them within cell 
organelles. This accumulation is consistent with the Western blotting results and 




3.3 Measurements of Transamidase Activity in Trypanosomal 
Lysate Using Fluorogenic Peptide Substrates 
 
 
3.3.1 Fluorogenic Peptide Substrates and Enzyme Assay Conditions 
 
The use of 7-amino-4-methylcoumarin (AMC) fluorogenic peptide substrates is 
a well-established method for the determination of protease specificity 
(Zimmerman et al., 1977). The substrate is extremely stable in solution and 
closely related to the natural peptide substrates. Specific cleavage of the anilide 
bond liberates the fluorogenic AMC group, thus allowing the simple 
determination of cleavage rates for individual proteases. The cleavage site for 
the GPI attachment (ω-site) in VSG is always one of the following three amino 
acids: Asp, Ser or Asn. In this assay Ac-S-V-L-N-AMC was used as a substrate 
to test the transamidase activity in lysates. The excitation and emission maxima 
of the amino-conjugated AMC substrates are 350 nm and 400 nm, respectively. 
Cleavage of the substrate by the transamidase to release the free AMC results in 
a shift of the excitation and emission maxima to 340 nm and 440 nm, 
respectively. Hydrolysis of AMC substrates was monitored fluorimetrically with 
an excitation wavelength of 360 nm and an emission scan from wavelength of 
370 nm to 530 nm on a spectrofluorimeter. The substrate was incubated together 
with trypanosomal lysates at 30°C for 1 h using 1 mM substrate in 50 mM 
citrate buffer at pH 6.5. As shown in Fig. 3.12, the emission maxima changed 
from 400 nm to about 440 nm after addition of trypanosomal lysates, suggesting 
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that the lysates contained an active transamidase, which catalysed the cleavage 
of the anilide bond.    
 
           

















Fig. 3.12 : Transamidase Activity in the Trypanosomal Lysate 
 
1 mM substrate was incubated with lysate at 30°C for 1 h. After incubation, the shift of 





3.3.2 Optimum pH of the Transamidase 
 
The optimum pH of the transamidase was detected by using trypanosomal lysate 
and Ac-S-V-L-N-AMC. Release of the fluorogenic AMC was dependent on pH 
value. The highest emission was acquired at pH 5.5, as can be seen from Fig. 
3.13. A rapid decrease in activity was measured at more acidic and basic 
condition. At pH 4.5 and pH 6.5 only about 10% activities were left. This result 
is consistent with the molecular feature of cloned TbGpi8, which has a pI of 
5.51. It shows a similarity with legumain, an asparaginyl endo-peptidase with a 
pH optimum 5.8 (Chen et al., 1997). 
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      Fig. 3.13: Optimum pH of the Transamidase in Lysate 
 
1 mM substrate was incubated with 10% trypanosomal cell lysate at 30°C overnight in 50 
mM citrate buffer ranging from pH 2.5 to 6.5 and 50 mM Hepes buffer ranging from pH 5.5 
to 9.5. The emission at 440 nm was measured on a spectrofluorimeter as described. 
           


















         Fig. 3.14: The Effect of Hydrazine on Transamidase 
 
Cell lysates were incubated with 1 mM substrate at 30°C for 1 h in the presence or absence of  
10 mM hydrazine. After incubation, the shift of emission maxima in samples was measured in 
a range from 370 nm to 480 nm. 
 




3.3.3 The Effect of Hydrazine on Transamidase Activity 
 
Nucleophilic attack by GPI, water or a nucleophile such as hydrazine is the final 
step of the transamidation reaction. In the reaction mixture, this reaction could 
be stimulated following the addition of 10 mM hydrazine. At about 440 nm a 
higher emission was observed than the sample without hydrazine (Fig. 3.14).  
 
 
3.3.4 DDT, pCMPSA and Transamidase Activity 
 
As previously shown, the GPI anchoring reaction in bloodstream stage 
trypanosomes is inhibited by the sulfhydryl alkylating reagent p-chloro-
mercuriphenyl sulfonic acid (pCMPSA) (Mayor et al., 1991; Sharma et al., 
1999) and it was thus supposed that a His and/or a Cys residue is located at the 
active site (Meyer et al., 2000). The effect of pCMPSA was thus detected in our 
assay.  
 
       
















Fig. 3.15: Inhibition of Transamidase with Sulfhydryl Alkylating Reagent 
 
Cell lysates (10%) were incubated with 1mM substrate in the presence of 1 mM pCMPSA or 
1 mM DTT at 30°C overnight.  
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As shown in Fig. 3.15, the release of AMC from fluorogenic peptide substrate 
was clearly inhibited. This result is consistent with the assumption that the 
trypanosome GPI transamidase contains a catalytically important sulfhydryl 
residue. The effect of DTT was also detected using the substrate. However, no 
obvious stimulation was acquired. It is possible that in the cell lysate existed 





3.4  TbGpi8 
 
 
3.4.1 Cloning of TbGPI8  
 
Degenerated oligonucleotide primers were designed against highly conserved 
regions based on those of yeast and human by using BLAST programme 
(http://www.ncbi.nlm.nih.gov/) and DNA fragments of T. brucei sequenced by 
TIGR (TIGR –Databases, http://www.tigr.org/). The 5’-sequence of the TbGPI8 
was amplified using primers GPI8AS1 and SLSE23 and cloned into pBS KS+. 
The 3’-sequence was amplified using primers GPI8SE3 and OT203N and cloned 
into pBS KS+. cDNA from the bloodstream form MITat 1.2 was used as 
template. After sequencing by GATC, 2 specific primers GPI8SE1 and 
GPI8AS2 were used to amplify the TbGpi8-ORF from bloodstream form 
MIT1.2 cDNA and cloned into pBS KS+. 2 clones were sequenced from the T7 
and T3 promoters of pBS KS+. Both clones gave the same sequence results. 
They are 1533 bp in length. The ATG start codon is at position 179. The ORF is 
960 bp long including the stop codon TAG and codes for a polypeptide of 319 
amino acids. The cDNA sequence and the corresponding protein sequence are 
given as follows. The start and stop codons and one N-glycosylation site and 




1      CGCTATTATT AGAACAGTTT CTGTACTATA TTGAAAAGTG TTAGATAGTT AAGTTAAATA 
61     AGAAATTTAA GTTGTAGTCC CCATCGCCGA GTACTGGGTT CGCACCAGCA CGGACGAGGA 
121    TAGGCGCAGA GGTTTCAAAC AAGTGGCAAG GGAAGAGTTG GTAAAGGGTT GCATTAACCT 
181    GAAGTGTGCT GACGTGGAAG GAGAAACCGA CGGCACTTAG GTTGAGTACA TAGTATCCGA 
241    TTAGTTGGAT CAGGCGCTTG CATATTTATT TCCAGCATTC GTTTTCTTGC AACTGGAAGG 
301    TGATGTTGCC CATGTTACTG TGGCTCGTGG CCAACCTCTT CTTAGCGCCG GCCGCGGAAG 
361    GCTTTCATGG TATGAATAAA ACCAACACCT GGGCCGTCAT CCTGTCCTCC TCCCGTTACT 
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421    TCTTTAATCT CCGTCATACA ACGAATGCGC TGGCCATGTA CCATTTGTGT CGAAAACACG 
481    GGATGGATGA CGACCACATC CTTGTCTTTC TTAGCGATAG CTACGCCTGC GATCCCCGCA 
541    AACCCAACCC AGCGACAATT TACGGAGCAC CTGCCCAAGC GGAGCAACCG AATCTATACG 
601    GCTGCAATAT TAGAGTGGAC TACGCGAGCT ACGATGTCGG TGTTCGCCGG TTCCTTGGCG 
661    TCCTGCAGGG CCGATATGAT GAGAATACTC CTCCTTCACG GCGTCTCGAC ACCGACGAGA 
721    ACTCGAACAT AATCATTTAC GCTGCTGGCC ACTCAGCTGA GAAATTCTTC AAGTTTCAGG 
781    ACTCGGAGTT CATGAGCTCA ACAGACATTG CGGACACCCT CATGATGATG TGGGAACAGC 
841    GACGATATCG TAAACTAGTT TTCCTTGTTG ACACATGCCG TGCGCTTTCC TTGTGTCTTG 
901    AGATAAAAGC ACCAAATGTC GTTTGCCTCG CCTCTTCCGA AGCGCATTTG GATAGCTACT 
961    CGCACCACCT TGACCCTCCA TCAGGCTTCA CTGTCATCAC GCGCTGGACG TTTGAGTTCC 
1021   TTGAGGTGCT CAAGGACTCG AAATGTCGGC CAGAAAACGG GGAAGTAACG CTGCTCCAGA 
1081   AATCATTTTA TGACTTCAAT TACGGTCCAG AGAGACTGAG TTTGCCCCAA CCACTCTCTG 
1141   AACCCGCGCA CTTCGATGCC GTGAACCGTC CAAACGCAAT CCGTGAGTGG AAAATGGACG 
1201   AATTTTTCTG TGAGCAGGAT CGGGATAAGA TCCCAGTAGA GTTACGTTAC GATTTGTTCT 
1261   AGTTCCACCA AAACCGAGGG GGGTATGTCC CATCAGTTGG AAGGAGAAAA ACGAACTTCC 
1321   TTCCCGAAAC TGACTCTCGG TGTCTATCTG GGATGGAGGA GAGAGAAAGA GGAGGGGTGA 
1381   AAGTAACATG AGGGGAACAT ATTACTGCTG TGCGATGACA GCACGACAAT ATTTGCTGCC 
1441   AATTATGCGG CTGTGTCTGT GCCTGTTATG TGGCTGTCCT TCTCCGTTTG TACATATGAA 
1501   ATATTTCTCA AATTTGCGTT CCTTTCTTCG GGGCGGCACC CCACCTCCTT CTGTTATTCC 
1561   TACCGGCTTA CGCGGGGCGG CTGTCCGGCA TCGTTAAACC GTCGGGGCAG GACGAAAAAA 




1      MLPMLLWLVA NLFLAPAAEG FHGMNKTNTW AVILSSSRYF FNLRHTTNAL AMYHLCRKHG 
61     MDDDHILVFL SDSYACDPRK PNPATIYGAP AQAEQPNLYG CNIRVDYASY DVGVRRFLGV 
121    LQGRYDENTP PSRRLDTDEN SNIIIYAAGH SAEKFFKFQD SEFMSSTDIA DTLMMMWEQR 
181    RYRKLVFLVD TCRALSLCLE IKAPNVVCLA SSEAHLDSYS HHLDPPSGFT VITRWTFEFL 
241    EVLKDSKCRP ENGEVTLLQK SFYDFNYGPE RLSLPQPLSE PAHFDAVNRP NAIREWKMDE 
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A m i n o  a c i d  n u m b e r  
 Fig. 3.16: Hydrophilicity Plot of the TbGpi8 
 
The TbGpi8 has a putative hydrophobic N-terminal ER-directing signal sequence 
(underlined), but shows no hydrophobic membrane-spanning region at its C-terminus as 
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   240PfGpi8
   200ScGpi8
   188SpGpi8








n y gh k q y dtc
   264TbGpi8
   290Lmgpi8
   320PfGpi8
   272ScGpi8
   261SpGpi8









   319TbGpi8
   349Lmgpi8
   400PfGpi8
   352ScGpi8
   341SpGpi8








   319TbGpi8
   349Lmgpi8
   480PfGpi8
   411ScGpi8
   380SpGpi8








   319TbGpi8
   349Lmgpi8
   493PfGpi8
   411ScGpi8
   380SpGpi8










Fig. 3.17: Sequence Alignment of the TbGPI8 with the Consensus Sequence of Other    
GPI8s 
 
TbGpi8 protein sequence of T. brucei aligned with L. mexicana, P. falciparum, S. cerevisiae, 
S. pombe and H. sapiens. Amino acid identities and similarities are highlighted; conserved 
amino acid residues are labeled. One potential N-glycosylation site is at N25(NKT), which is 
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As calculated from the amino acids sequence, TbGpi8 shows a pI of 5.51 and a 
molecular mass of 37 kDa or 35 kDa if the signal sequence is removed. 
Compared with other eukaryotic organisms, TbGpi8 shows a high degree of 
homology. According to the results of Meyer et al. (2000), ScGpi8 alleles 
mutated at Cys199 or His157 are non-functional, they are unable to suppress the 
lethality of ∆gpi8 mutants. Alignment in Fig. 3.17 indicates that Cys193 and 
His142 of TbGpi8 are conserved and located at the consensus position of the 
Cys199 and His157 of ScGpi8. They should be the active site residues. The 
hydrophilicity plot of TbGpi8 (Fig. 3.16) shows one hydrophobic region at the N 
terminus, which may serve as a signal peptide for translocation into the ER. 
Unlike ScGpi8, TbGpi8 has no hydrophobic region at the C terminus.  
 
 
3.4.2 Cloning of TbGPI8 in Expression Plasmid 
 
Two different expression systems were used to express TbGpi8. One was 
RGS6xHis tag system, which produced RGS6xHis-tagged TbGpi8, that, 
following expression, could be affinity purified on Ni-NTA matrices. The other 
was the MBP fusion protein system. The expressed fusion protein MBP-TbGpi8 
could be affinity purified using amylose resin and further be digested with 
 







Fig. 3.18: Amplified TbGPI8 in pBS KS+  
Lane 1: 1 kb marker 
Lane 2: amplified TbGPI8 
 
 
enterokinase to produce TbGpi8. To clone the TbGPI8 into the expression 
vectors, the plasmid pBS KS+ containing TbGPI8 cDNA was used as a template. 
The plasmid pRSET B was used for the RGS6xHis tag system and plasmid 
pMAL-c2E was used for the MBP fusion system to heterologously express the 
TbGpi8. TbGPI8 was amplified using primers GPI8-AS/GPI8-His-SE2 or 
GPSEMAL1/ GPASMAL2. By PCR, a DNA fragment of about 900 bp in size 
was produced (Fig. 3.18). This fragment did not contain the sequence for the N-
terminal signal peptide. 
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For the 6xHis tag system the PCR product was digested using the restriction 
enzymes NheI/EcoRI and was ligated into the vector also digested with 
NheI/EcoRI. The RGS6xHis tag was located at the N-terminus of the same 
reading frame of TbGpi8.  
  
For the MBP fusion system, the PCR product and the plasmid were both 
digested with KpnI and ligated thereafter. The control PCR was performed using 
primer PMALSE1/GPASMAL2 to check for the correct orientation. TbGpi8 was 
placed at the C-terminus of MBP.  
 
After transformation into E. coli 2566, all the plamids isolated from positive 
clones were restriction digested again to control correctness. In the RGS6xHis 
tag system, 6 positive clones were selected and digested with NheI/EcoRI. As 
shown in Fig. 3.19, 3 of them (clone 3, 4 and 8) produced the correct insert band 
while 3 others did not. Therefore, the 3 correct clones were used to express 
TbGpi8. 
 










Fig. 3.19: NheI/EcoRI-Digestion of the 
Expression Vectors 
 
Lane 1: 1kb marker 
Lane 2: 100 bp marker 






3.4.3 Expression of TbGpi8 in E.coli  
 
3.4.3.1 Induction and Purification of RGS6xHis-TbGpi8 
 
For expression of TbGpi8, the E. coli strain containing plasmid pRSET B with 
TbGPI8 was induced overnight with 0.3 mM IPTG at 15°C. Cells were lysed 
and centrifuged to separate supernatant and pellet. The supernatant was 
subjected to affinity purification using Ni-NTA matrices. The results of 
SDS/PAGE (Fig. 3.20) indicated that in the induced cells a protein with about 
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35 kDa was expressed at high level. This molecular mass corresponded to the 
molecular mass calculated from the TbGPI8 sequence (lane 2), which was 
constructed in the expression plasmid pRSET B without the N-terminus. This 
protein could be affinity purified using a Ni-NTA matrix (lane 3), thus giving 
further evidence for the correct expression of TbGpi8. The RGS6xHis-TbGpi8s 
were expressed at high level, but most of them formed inclusion bodies. 
Although the RGS6xHis-TbGpi8s could be isolated from the supernatant in 
native form, the amount was very low as judged from SDS-PAGE. If the 
RGS6xHis-TbGpi8 was isolated in denaturing conditions, the protein seemed 
















                           Fig. 3.20: Expression of RGS6xHis-TbGpi8 in E. coli 
 
After induction of RGS6xHis-TbGpi8 in E. coli with 0.3 mM IPTG overnight at 15°C, the 
cell was sonicated in short pulses of 15 sec for 15 min each. The supernatant was applied to a 
Ni-NTA column. The RGS6xHis-TbGpi8 was eluted with elution buffer containing 250 mM 
imidazole. Lane 1: not induced cell; lane 2: with 0.3 mM IPTG induced cell; lane 3: using 
Ni-NTA matrices isolated TbGpi8 
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                          Fig. 3.21: Induction and Purification of MBP-TbGpi8 
 
Cells were induced with 0.3 mM IPTG and sonicated in short pulses of 15 sec for 15 min. 
The supernatant was applied to an amylose column. The MBP-TbGpi8 was eluted with 
elution buffer containing 10 mM maltose. The protein concentration was measured at 280 
nm. Panel a: Elution curve of MBP-TbGpi8; Panel b: SDS/PAGE analysis of MBP-TbGpi8. 
Lane 1: Lysate from not induced cells; lane 2: Cells induced with 0.3 mM IPTG; lane 3: 
Purified MBP-TbGpi8 using amylose resin.                                                       
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3.4.3.2 Induction and Purification of MBP-TbGpi8 
 
The E. coli strain containing TbGPI8 in plasmid pMAL-c2E was induced 
overnight with 0.3 mM IPTG at 15°C. The cells were sonicated in short pulses 
of 15 sec each for about 15 min and centrifuged. The supernatant was supplied 
for affinity chromatography using amylose resin. As shown in Fig. 3.21, the 
MBP-TbGpi8 was induced by IPTG at high level. Following affinity 
chromatography, the MBP-TbGpi8 was purified as a single band on the 
SDS/PAGE showing a molecular mass of 80 kDa. From a 50 ml culture, about 2 
mg of MBP-TbGpi8 was purified.  
 
3.4.3.3 Cleavage of MBP-TbGpi8 Using Enterokinase  
 
To obtain TbGpi8, enterokinase cleavage was carried out at a w/w ratio of 2.5% 
 
 






kDa 1 2 3 4
 
 
                                 Fig. 3.22: Enterokinase Treated MBP-TbGpi8 
 
Enterokinase cleavage was carried out at an enzyme/MBP-TbGpi8 (w/w) of 1/40 in Tris 
buffer, 50 mM, pH 8.0 at room temperature for 8 h. The cleavage mixture was subjected to 
an amylose column again to remove MBP from the TbGpi8. Samples were analysed by 
SDS/PAGE. Lane 1: Purified MBP-TbGpi8 before treatment with enterokinase; lane 2: 
MBP-TbGpi8 after treatment with enterokinase; Lane 3: TbGpi8 isolated from the cleavage 
mixture after a second run through the amylose column; lane 4: Elution buffer containing all 
retained protein bands from the amylose resin (cleaved MBP bound on amylose column). 
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~ 5% the amount of fusion protein. The reaction mixture was incubated 
overnight at room temperature. After cleavage with enterokinase, many different 
degraded products appeared on SDS/PAGE (Fig. 3.22, lane 2) and the MBP-
TbGpi8 was not cleavage completely. This indicated that the fusion protein was 
not stable and that the enterokinase was not efficient to cleave the fusion protein. 
If the cleave mixture was applied to the amylose resin column again, the flow-
though revealed only one protein band by silver staining (lane 3). This protein is 
supposed to be the pure TbGpi8, although its apparent molecular mass is a little 
higher than that calculated from the amino acid sequence. We assume that this 
protein consisted of the entire TbGpi8 containing some additional amino acids 
from the MBP, insufficient however to bind to the amylose resin. It is also 
possible that the standard MW marker was not very accurate under the 
employed electrophoresis conditions. The amylose resin column retained the 
maltose binding protein from the cleavage mixture successfully. As shown in 
Fig. 3.22, lane 4, almost all the degrading products were MBP linked, because 
they did not appear in the flow though of the amylose resin column, but were 
eluted using the corresponding elution buffer. 
 
 
3.4.4 Fusion Protein GFP-C-TerminusVSG221 
 
To measure the activity of the purified TbGpi8, a suitable substrate was needed. 
For this reason, a fusion protein GFP-C-terminusVSG221 was produced in E. 
coli using molecular cloning methodology. This protein consisted of the C-
terminal sequence of MITat 1.2 linked to GFP. Since the C-terminal sequence 
contained the correct cleavage site, it was supposed to serve as a substrate for 
GPI anchor exchange. RT-PCR was performed on 221 bloodstream form cDNA 
with primers 221-PEPSE/221-PEPAS. The ~300 bp fragment was kinased and 
ligated to oligonucleotids 221-5ADA/221-3ADA to create the last codons of 
VSG 221 C-terminus and the sticky end compatible to SapI cut pTYP1. The 
ligated product was treated with NdeI, purified by agarose gel electrophoresis 
and cloned into NdeI/SapI treated pTYB1, rendering plasmid pTYB1::221PEP. 
EGFP gene was amplified with primers 3GFP-NDE/5GFP-NDE from plasmid 
pEGFP-N1. The product was cut using NdeI and cloned into NdeI treated and 
dephosphorylated pTYB1:: 221PEP. The primers 5GFP-NDE/221-PEPAS were 
used to check for the correct orientation of the fragment in the plasmid. After 
sequenced by GATC, the plasmids from correct clones were transformed into E. 
coli 2566 and induced overnight with IPTG at 15°C. Since the induced fusion 
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protein could not be visualized by Coomassie staining, Western blotting was 
performed using anti-C-terminusVSG221 antibodies to control the fusion 
protein. As indicated in Fig. 3.23 (lane 2), the induced fusion protein (about 95 
kDa) was synthesized at a very low abundance (arrow a) but a protein of about 
40 kDa was detected at a relative high level. These data indicate that the fusion 
protein intein-CBD-GFP-C-terminusVSG221 was degraded or cleaved in vivo. 
According to the molecular weight, this degraded protein of about 40 kDa might 
be the GFP-C-terminusVSG221. Further results (lane 3 and 4) suggest that most 
of GFP-C-terminusVSG221 stayed in the cell pellet but not in the cell 
















   
                   Fig. 3.23: Expression and Isolation of GFP-C-TerminusVSG221 
 
Expression of the fusion protein was induced by 0.3 mM IPTG overnight at 15°C. Cell 
lysates were applied to SDS/PAGE and Western blotting analysis using anti-C-terminus 
VSG221 antibody. Lane 1: Lysate of not induced cells; lane 2: Lysate of induced cells; lane 
3: Cell pellet; lane 4: Cell supernatant. Arrow a: Fusion protein intein-CBD-GFP-C-terminus 
VSG221; arrow b: Degraded GFP-C-terminus VSG221. 
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3.4.5 In vitro Activity Assay of the TbGpi8 
 
3.4.5.1 In vitro Transamidase Assay Using GFP-C-TerminusVSG221 as 
Substrate 
 
As shown in Fig. 3.23, most of the fusion protein intein-CBD-GFP-C-
terminusVSG221 was already self cleaved in vivo into the target protein GFP-C-
terminusVSG221, which was highly hydrophobic and remained in the pellet. If 
the supernatant contained some soluble intein-CBD-GFP-C-terminusVSG221 
was applied to chitin column and conducted an on column cleavage, GFP-C-
terminusVSG221 could not be eluted from column with moderate solution (data 
not show). Since it proofed difficult to isolate pure GFP-C-terminusVSG221, the 
corresponding E. coli lysate was directly be used as a substrate to test the 
activity of TbGpi8 in vitro. The anti-C-terminusVSG221 antibody was used for 
Western blotting to detect the C-terminus cleavage by TbGpi8. Trypanosomal 
lysate and enterokinase treated MBP-TbGpi8 as enzymes were incubated with E. 
coli lysate containing induced GFP-C-terminusVSG221 as substrate and 
hydrazine at 30°C for 1 h (Fig. 3.24).  
                         
                                 
1 2 3 4 5
 
 
                                      Fig. 3.24: In vitro Activity Assay of the TbGpi8 
 
E. coli lysates containing the GFP-C-terminusVSG221 was incubated with trypanosomal 
lysate and enterokinase treated MBP-TbGpi8 at 30°C for 1 h. After SDS/PAGE, proteins 
were transferred onto a nitrocellulose membrane and detected with anti-C-terminusVSG221 
antibodies. Lane 1: E. coli lysate containing induced GFP-C-terminusVSG221; lane 2: 
Trypanosomal lysate (This protein band showed cross reaction with anti-C-terminusVSG221 
antibodies. It was not VSG); lane 3: E. coli lysate containing induced GFP-C-
terminusVSG221 incubated with trypanosomal lysate; lane 4: E. coli lysate containing 
induced GFP-C-terminusVSG221 incubated with trypanosomal lysate and 10 mM hydrazine; 
lane 5: E. coli lysate incubated with enterokinase treated MBP-TbGpi8. 
 
 
If the GFP-C-terminusVSG221 was incubated with trypanosomal lysate (lane 3), 
the C-terminus of the fusion protein was cleaved to some extent, because a 
relatively weak signal was obtained as comparing with the sample in the absence 
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of trypanosomal lysate (lane 1). The weakest signal was obtained by addition of 
10 mM hydrazine (lane 4). Enterokinase treated MBP-TbGpi8 did not show any 
activity in this experiment (lane 5). These results suggest that the fusion protein 
GFP-C-terminusVSG221 is a suitable substrate for detection of the transamidase 
activity in lysates. In trypanosomal lysates, the transamidase complex could 
cleave the C-terminus from the fusion protein at high efficiency. However, 
cleavage of the C-terminus by heterogeneous expressed TbGpi8 could not be 
detected using this method even in the presence of hydrazine. Possibly, this 
method is not sensitive enough, because the minor decrease of substrate is 
normally difficult to be measured. 
 
3.4.5.2 In vitro Transamidase Assay Using AMC Linked Peptide as 
Substrate  
 
In this assay, Ac-S-V-L-N-AMC was used as substrate to check the 
transamidase activity of recombinant TbGpi8.  






















 Fig. 3.25: Stimulation of the Transamidase Activity in Trypanosomal Lysates by      
TbGpi8 
 
Trypanosomal lysate and substrate were incubated at 30°C overnight in the presence or 
absence of TbGpi8. The emission spectrum was measured in the range from 370 ~ 530 nm. 
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This method proofed to be much more sensitive than the method using GFP-C-
terminusVSG221, because the amount of AMC produced by the transamidase 
activity was detected at nM level. In this assay, enterokinase treated MBP-
TbGpi8 was first incubated with lysate and Ac-S-V-L-N-AMC overnight at 
30°C in citrate buffer containing 10 mM hydrazine, pH 5.5. The transamidase 
activity was significantly stimulated by TbGpi8 (Fig. 3.25). The release amount 
of AMC was increased obviously. These results indicate that the recombinant 
TbGpi8 had some effect on the transamidase activity in trypanosomal lysates. 
According to the amino acid sequence of TbGpi8, it is expected to be a soluble 
protein. Therefore, addition of TbGpi8 to the cell lysate could increase the 
TbGpi8 concentration and then enhance the enzyme activity of the transamidase 
enzyme complex. GPI anchoring unit is a transamidase complex. Mutant GAA1 
failed to express GPI-anchored proteins on the cell surface (Benghezal et al., 
1996; Hamburger et al, 1995).  















 Fig. 3.26: Transamidase Activity of the Heterogeneous Expressed TbGpi8 
 
TbGpi8 and MBP-TbGpi8 were incubated with substrate at 30°C overnight. The shift of 
emission maxima in samples was measured from 370 nm to 530 nm. Samples without TbGpi8 
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At least two gene products participated in the transamidation reaction. However, 
Gpi8 bears resemblance to several plant and invertebrate proteases. It could have 
some proteolytic activity itself. Based on this assumption, the transamidase 
activity of TbGpi8 was tested in the absence of trypanosomal lysate. As shown 
in Fig. 3.26, if the Ac-S-V-L-N-AMC was incubated with TbGpi8, the emission 
at 440 nm increased significantly as comparing with Ac-S-V-L-N-AMC 
incubated in buffer alone. The AMC was produced by enterokinase treated 
MBP-TbGpi8, whereas the AMC was not produced by intact MBP-TbGpi8. This 
result indicated that recombinant TbGpi8 has a peptidase activity itself and 
could cleave Ac-S-V-L-N-AMC at the P1 position, which corresponds to the ω 
position in VSG, leading to the GPI addition within the cell. 
 
 
3.4.6 Anti-TbGpi8 Antibodies 
 
3.4.6.1 Production and Determination of the Titer of Anti-TbGpi8 
Antibodies 
 
The MBP-TbGpi8 was heterologously expressed at high level but enterokinase 
cleavage was not very efficient and led to formation of many degraded proteins. 
TbGpi8 isolated from this mixture run at a relative high apparent molecular 
mass. Therefore, the fusion protein MBP-TbGpi8 was used as antigen to 
produce antibodies by immunisation of a hen. IgY was isolated from egg yolk 
by using PEG precipitation (See methods). The antibody titer was measured 
using ELISA with the respective antigen coated to plates. A titer of 1:100,000 
each 10 ml preparation from 3 yolks was achieved.   
 
3.4.6.2 Purification of the Specific Anti-TbGpi8 IgY 
 
The fusion protein MBP-TbGpi8 was used to produce anti-TbGpi8 antibodies. 
By using PEG precipitation a mixture of IgYs against different antigens was 
isolated. (Fig. 3.27, lane 1). In order to obtain pure anti-TbGpi8 IgY, anti-MBP 
IgY was removed from antibody mixture by using MBP coupled to an amylose 
column. Anti-TbGpi8 IgY was then further purified using an MBP-TbGpi8-
amylose column from the flow through (Fig. 3.27, lane 2). In order to check the 
specificity of the anti-TbGpi8 IgY, E. coli strain with pTYB1::MBP was used in 
Western blot analysis. The synthesis of MBP was induced by 0.3 mM IPTG. If 
the IgY mixture isolated from egg yolk was not subjected to further purification 
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by using affinity chromatography, it gave a very strong signal on the Western 
blot by the induced MBP (Fig. 3.28, panel a). After purification, induced MBP  
 











Fig. 3.27: IgY Isolated by PEG Precipitation and 
Affinity Chromatography 
 
IgY was precipitated from egg-yolk by using 12% 
PEG6000 (lane 1) and subjected to affinity 
chromatography using two columns with MBP and 
MBP-TbGpi8 (lane 2). After SDS/PAGE, proteins 














                          Fig. 3.28: The Specificity of the Purified Anti-TbGpi8 IgY 
 
E. Coli cells containing MBP gene were incubated in the presence (lane 2) and absence of 0.3 
mM IPTG (lane 1). After SDS/PAGE, proteins in induced cells and not induced cells was 
transferred on to nitrocellulose membrane and detected with PEG 6000 precipitated IgY 
(panel a) and affinity purified IgY specific against TbGpi8 respectively (panel b).    
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could not be detected on the plot (Fig. 3.28, panel b). This result indicated that 
the anti-MBP IgY was removed from the IgY mixture efficiently by the affinity 
chromatography. Although the anti-TbGpi8 IgY was affinity purified, it had still 
little cross-reaction with an unknown protein in E. coli. 
 
 
3.4.7 Localization of TbGpi8 Using Isolated Anti-TbGpi8 IgY 
 
The localization of TbGpi8 was performed using anti-TbGpi8 IgY. Cell nucleus 
and kinetoplast were labelled with bisbenzimid. The results are shown in Fig. 
3.29. In the procyclic cell (panel a), clearly stained vesicles are shown to lie 
between nucleus and kinetoplast. This position is known to represent the Golgi 
apparatus. In bloodstream form cells, similar vesicles were shown to lie not only 
between nucleus and kinetoplast but also closely behind the nucleus.  
 




                                          Fig. 3.29: Localization of the TbGpi8  
 
Cells in procyclic form (panel a) and in bloodstream form (panel b) were fixed with 1% 
formaldehyde in HBS buffer, and then the localization of the TbGpi8 was visualized by 
specific anti-TbGpi8 antibody developed from chicken. The second antibody was FITC 
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3.4.8 Localization of the Pro-VSG 
 
It was presumed that replacement of the C-terminal signal sequence with GPI 
moiety is catalysed by an ER-localized transamidase rapidly after translation 
(Mayor & Maxfield, 1995; Maxwell et al., 1995). According to the results 
presented in 3.1.4, in the trypanosomal lysate exists some pro-VSG, which could 
be detected by anti-C-terminus antibody. The results of 3.4.7 indicate the main 
component of transamidase was located in Golgi but not in ER. It is possible 
that the in ER newly formed pro-VSG must transported to the Golgi to finish 
anchor exchange, which caused some pro-VSG accumulated in ER. In order to 
check this assumption, the localization of pro-VSG was performed by 
immunofluoresence using anti-C-terminus antibodies. As shown in Fig. 3.30, the 
most of the pro-VSG was localized in the ER (panel b), which emerge from the 
nuclear envelope and ramify through the cytoplasm. These results confirmed the 
Golgi localization of TbGpi8 and allowed to explain the existence of a steady 













Fig. 3.30: Localization of the Pro-VSG 
 
Trypanosomal cells in bloodstream form were 
fixed with 1% formaldehyde in HBS buffer. 
Anti-C-terminusVSG221 antibody was used to 
localize pro-VSG within the cell. The second 
antibody was FITC labeled anti-rabbit IgG. 
Panel a: Nucleus and kinetoplast labelled with 
bisbenzimid; panel b: Cells labelled with anti-C-
terminus antibody; panel c: Overlay of panel a 
and panel b. 
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3.4.9 Analysis of Trypanosomal Lysate Using Isolated Anti-TbGpi8 IgY 
 
The sequence of TbGpi8 predicted a protein containing 302 amino acids and a 
molecular mass of 37 kDa or 35 kDa if the signal sequence is removed. The 
hydrophilicity plot of the TbGpi8 (Fig. 3.31) reveals one hydrophobic region at 
the N terminus, which qualifies as a signal peptide for translocation into the ER 
(von Heijne, 1986). The cleavage site for the signal peptidase is predicted 
between the residues Ala 17 and Ala 18. TbGpi8 in trypanosomal lysate was 
detected by SDS/PAGE and Western blotting using affinity purified anti-TbGpi8 
IgY. As shown in Fig. 3.31, this antibody specifically detected 3 bands of ~37 
kDa, ~35 kDa and ~33 kDa in trypanosomal lysates. According to the molecular 
weight and amino acids sequence, TbGpi8 contains a N-terminal signal 
sequence and a N-glycosylation site. The N-terminal signal sequence should not 
be detected because it is cleavaged during the translation. The size difference 
between the 35 and 37 kDa form of TbGpi8 may be due to glycosylation. The 
state of glycosylation of TbGpi8 has not been investigated yet. This ~33 kDa 









Fig. 3.31: TbGpi8 in Trypanosomal Lysate 
 
Trypanosomal lysate was separated by SDS/PAGE and 
analysed with affinity purified chicken anti-TbGpi8 



















4.1 The in vitro Translation System 
 
By using limited lysis under hypotonic condition, which just led to cell lysis but 
not lysis of organelles, a potent small molecular mass translation inhibitor was 
prevented from being released into the cell lysate and a high translation activity 
was obtained. However, these translationally active lysates of trypanosomes had 
no reinitiation activity. The main problem seems to be phosphorylation of 
crucial initiation factors like eIF-2 or eIF-4. Regulation of translation initiation 
is an important component of the cellular stress response. By preparation of cell 
lysates, several factors (temperature, pressure, pH changes, etc.) appeared to 
invoke the stress-mediated regulation of eIFs to alter the translational capacity 
by phosphorylation. This mediates the binding of the initiator Met-tRNA to the 
ribosome or recruits mRNAs to the ribosome by recognition of the 5’-m7G cap 
and serves as a central adapter by binding to various translation factors and 
regulators (Sheikh et al., 1999). Nevertheless, this cell free system is very useful 
as it allows the study of post-translational modifications in vitro.  
 
VSG of the T. brucei bloodstream form is known to be glycosylated leading to a 
range of structures including high mannose and complex types. This work 
provided evidence for in vitro N-glycosylation. N-glycosidase F treatment and 
concanavalin A blotting clearly revealed a coupling of in vitro translation and in 
vitro modifications. The cotranslational translocation into the ER-lumen is an 
essential prerequisite for N-glycosylation. Therefore, demonstration of N-
glycans is a good indicator for translocation of newly formed proteins into the 
ER-lumen in vitro. Upon mixing trypanosomal lysate with reticulocyte lysate 
and reinitiation of a translation, the newly formed proteins did not undergo any 
modification, i.e. reinitiation and translation happened in reticulocyte lysate but 
a coupling with trypanosomal ER membranes and translocation into 
trypanosomal ER was not achieved. 
 
Within trypanosomal lysates pro-VSG containing the uncleaved C-terminus 
could be regularly detected no matter whether in vitro translation was conducted 
or not. Among the characterized GPI proteins, the number of residues within the 
COOH-terminal signal peptide varied from about 10 to 30 mainly hydrophobic 
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amino acids. In trypanosomes it would be exchanged by GPI anchor within 1 
min of completion of the polypeptide (Ferguson et al., 1986). Our data suggest 
that the processing was delayed or incomplete and pro-VSG accumulated. 
According to Kodukula (1991), processing of pro form miniPLAP to the mature 
form was also delayed considerably. After 90 min, only approximately 40% of 
the total translated material appeared as mature miniPLAP. A possible reason 
for this lag is the amount of COOH-terminal transamidase activity within the ER 
membrane. In our experiments, the appearance of pro-VSG is perhaps due to a 
relative low amount of COOH-terminal transamidase in ER as compared with 
the Golgi apparatus but this will be considered later. 
 
Our main interest to develop a cell free system was to study the addition of GPI 
anchor, which is thought to be a single-step reaction performed by a 
transamidase (Udenfriend et al., 1995). As VSG is a dominant protein in 
trypanosomes, accounting for about 10% of the total amount of proteins and is 
constitutively synthesized at a high rate (about 8% of total protein biosynthesis), 
this parasite seems to be perfectly suited for such studies. There are several 
methods to determine the GPI anchor. Due to myristate exchange (reactions 
occurring on mature VSG), GPI labeling with tritiated myristic acid could not be 
used to investigate GPI anchor exchange. Radiolabeling with either GDP-
[14C]mannose or [14C]ethanolamine could be detected but was rather poor 
probably due to a substantial amount of preformed GPI precursor molecules 
within the microsomal membranes. Due to the high activity of endogenous GPI-
PLC, phase separation with Triton X-114 is not suitable for detection of the GPI 
anchor, because newly formed mfVSG was transformed to sVSG very quickly. 
ZnCl2, an inhibitor of GPI-PLC, could inhibit the enzyme only partially. Some 
other inhibitors, however, had a notable impact on translation. For these reasons, 
two important substances were used for the measurement of the anchor addition 
in vitro. One is biotin-lys-tRNAlys, which allows to purify newly formed VSG 
from the translation mixture and to eliminate the interference of ‘old’ VSG. In 
VSG there are more lysine residues than methionine. By using an ECL 
fluorescent detection kit the newly translated proteins were easily detected. This 
proofed to be a very sensitive and timesaving method for in vitro translation. 
The other was the use of anti-CRD antibodies. These antibodies have been 
originally prepared from Leishmania cells and show no cross reactivity with the 
respective VSG variant as confirmed by using isolated mfVSG. The purified 
newly formed VSG could be detected with anti-CRD antibodies, clearly 
showing that the GPI is added to the premature VSG molecule in vitro. In 
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addition, some newly formed VSGs were kept in membrane form in the 
presence of 0.2 mM ZnCl2, and the VSG of MITat 1.4 could be labelled by 
using UDP-[14C]galactose, which also provided direct or indirect evidence for 
the GPI anchor exchange capability in vitro.  
 
 
4.2 In vivo Research of GPI Addition to VSG 
 
The mature GPI anchor precursor is added to the carboxyl-terminus of protein 
via an amide bond formed between the carboxyl-terminus and ethanolamine. A 
carboxyl-terminal sequence signals its own cleavage and replacement with the 
GPI anchor. This replacement reaction is though to be a transamidation 
(Udenfriend et al., 1995). In a cell-free system, addition of hydrazine resulted in 
the linkage of hydrazine in place of the GPI-anchor forming a hydrazide of 
miniPLAP. In the work presented here, trypanosomes MITat 1.2 were cultured 
in the presence of 10 ng/ml tunicamycin to produce nonglycosylated VSG. This 
VSG runs relatively faster in SDS/PAGE than glycosylated VSGs and allows to 
be analysed further without interference of glycosylated VSG. VSG MITat 1.2 
has two N-glycosylation sites. Appearance of additional 2 VSG bands with 
lower molecular weight may be due to different N-glycosylation, the VSG with 
just one glycosylated site and the nonglycosylated VSG. After Western blotting 
analysis, just the lowest band could be detected by anti-CRD antibodies whereas 
the other could not. After translation and processing, many C-terminal forms 
may be formed and could not be characterized by anti-CRD antibodies, such as 
mfVSG, free VSG (without anchor), pro-VSG (with C-terminal signal peptide). 
This needs to be further characterized. Nevertheless, my experiments have 
successfully given evidence that small nucleophiles are capable of substituting 
for GPI in the anchoring reaction, because in the presence of hydrazine the 
produced VSG could not be detected by anti-CRD antibody and in the presence 
of biotin-hydrazine the biotin tag on VSG could be detected by streptavidin. 
 
The GPI anchor appears to act as a signal to target proteins to the apical portion 
of the plasma membrane (Lisanti et al., 1989; 1990) and may also function in 
the export of proteins from the ER. Disruption of GPI attachment, either in cell 
lines that are deficient in GPI precursor or by mutation of GPI-peptides, can 
result in the retention of mammalian GPI-anchored proteins in the ER (Moran et 
al., 1992; Field et al., 1994). McDowell et al. (1998) have investigated the 
transport of VSG∆gpi. Their studies also indicated that the GPI-minus VSGs 
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accumulate in the endoplasmic reticulum (ER). The delayed forward transport 
cannot be accounted for by failure to fold/assemble in the absence of a GPI 
anchor. The GPI structure acts in a positive manner to mediate efficient forward 
transport of some, and perhaps all, GPI-anchored proteins in the early secretory 
pathway of trypanosomes. Therefore, in my experiment, if the GPI anchor was 
replaced by a small nucleophile, similar results were expected. 
Immunolocalization of VSG indicated that VSG-hydrazide accumulated in 
several extensively stained compartments between nucleus and kinetoplast. 
Obviously they do not accumulate in the tubular structures of ER. Normally, 
VSG is transported along the classical intracellular route for glycoproteins and is 
delivered to the flagella pocket, where it is integrated into the surface coat 
(Duszenko et al., 1988). Accumulation of a protein within ER or Golgi can 
occur for different reasons, including improper folding, absence of exit signals, 
or recycling. A possible explanation for my results is that GPI-minus VSG, i.e. 
VSG-hydrazide, was arrested within the Golgi and trans-Golgi region and the 
incorporation of newly synthesized VSG into the surface coat was highly 
retarded. As compared with results obtained by McDowell et al. (1998) using 
VSG∆gpi, we found a different localization for the accumulated VSG-
hydrazide. The VSG∆gpi was synthesized as a C-terminus-minus VSG within 
the ER and thus the retention begins already in the ER. In my experiments, VSG 
was synthesized as a pro-VSG in the ER as usual, which has a C-terminal 
peptide as membrane anchor. This peptide could mediate efficient transport 
from ER to Golgi apparatus where the pro-VSG was transformed to VSG 
hydrazide in the presence of hydrazine and the transamidase complex. From 
now on, VSG existed as a GPI-minus VSG and could not be exported to the cell-




4.3 The Transamidase Activity in Trypanosomal Lysates and the 
Synthetic Ac-S-V-L-N-AMC Substrate 
 
The substrate Ac-S-V-L-N-AMC was quite efficiently cleaved at the P1 position 
in trypanosomal lysates and the fluorogenic AMC was released. This reaction 
could be activated by 10 mM hydrazine. Hydrazine is a well-known nucleophilic 
acceptor in transamidase and transpeptidase catalysed reactions (Tate et al., 
1974). Therefore, we may suppose this reaction is performed by a transamidase 
in trypanosomal lysates. Additionally, enzyme activity was inhibited by 1 mM 
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pCMPSA, a sulfhydryl alkylating reagent, completely. This result is consistent 
with the proposal that the trypanosome GPI transamidase contains a catalytically 
important sulfhydryl residue. About 30 families of peptidases are dependent on a 
cysteine residue at the active centre (Rawlings and Barrett, 1994). Most 
protozoa produce cysteine endopeptidases during at least one stage of their life 
cycle. Most of them are members of the papain super family. These are 
predominantly lysosomal enzymes, which do not show substrate specificity for 
asparaginyl residues. They have a preference for bulky hydrophobic residues at 
the P2 position such as Val and Phe (Harris et al., 2000). Therefore, the 
proteolytic activity detected using Ac-S-V-L-N-AMC as a substrate can be due 
to the transamidase activity of TbGpi8, which has a high homology to other 
known Gpi8 and C13 cysteine peptidases. Legumain is a C13 cysteine 
endopeptidase that shows a significant homology with Gpi8. Its maximal 
activity is seen at pH 5.8 under assay condition (Chen et al., 1997). The 
optimum pH of the transamidase in trypanosomal lysates in my experiments was 
at pH 5.5. These data suggest that the transamidase activity detected in 
trypanosomal lysates is due to TbGpi8, which may function better in acidic 
condition than neutral condition. However, at present there is not enough 
evidence to confirm that these assumptions are valid in vivo.  
 
 
4.4 Cloning, Expression and Characterization of TbGpi8  
 
Transamidase-deficient cells are expected to accumulate complete GPIs as well 
as the GPI precursor proteins. This phenotype is exhibited by two yeast mutants, 
gaa1 and gpi8 and a mammalian mutant cell line (class K) (Mohney et al., 1994; 
Benghezal et al., 1995; Hamburger et al., 1995). Benghezal et al. (1996) have 
cloned the GPI8, which encodes a transmembrane ER protein with a large 
luminal domain. Yeast Gpi8 has 27.5% identity to a jack bean asparaginyl 
endopeptidase, which shows transpeptidase activity in vitro (Abe et al., 1993). 
They belong to a novel cysteine proteinase family. The homology with proteases 
does not prove, but at least suggests that Gpi8 is directly involved in the 
proteolytic removal of the GPI anchoring signal.  
 
To gain a better understanding of the properties of TbGpi8, TbGPI8 cDNA was 
cloned and TbGpi8 was expressed and characterized. It showed significant 
homology with other known GPI8 genes. The size of the cDNA is very similar 
to the LmGPI8. A hydropathy analysis showed that TbGpi8 has a N-terminal 
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hydrophobic domain that is likely to serve as a signal for ER localization. It can 
be assumed that TbGpi8 is glycosylated in vivo as it contains the signal peptide. 
According to the amino acids sequence, TbGpi8 contains one N-glycosylation 
site, being on Asn 25, which is close to the most probable cleavage site for the 
signal peptidase (von Heijne, 1986). Western blotting analysis of trypanosomal 
lysates with specific anti-TbGpi8 antibodies also suggests this assumption of N-
glycocylation.  
 
Like LmGpi8, TbGpi8 lacks a C-terminal hydrophobic domain found in yeast 
and human GPI8s that is predicted to be a transmembrane helix (Benghezal et 
al., 1996). Human Gpi8 mutant lacking the transmembrane domain retained its 
activity to complement class K mutant cells, indicating that the transmembrane 
domain is not necessary (Ohishi et al., 2000). For the transamidase activity, 
however, the GPI8 protein should be anchored to the luminal leaflet in order to 
interact with the preformed GPI anchor. Hilley et al. (2000) suggested that 
attachment of L. mexicana GPI8 to the ER membrane may thus require one or 
more other integral membrane proteins. A possible candidate is Gaa1p. The 
exact role of Gaa1p was not elucidated yet, but it had been demonstrated that 
Gaa1p and Gpi8 form a protein complex (Ohishi et al., 2000). In human and 
yeast cells, Gaa1p is a luminally oriented ER glycoprotein containing several 
transmembrane domains (Hamburger et al., 1995). It is possible that Gaa1p is 
required for a precursor protein to form a carbonyl intermediate with the GPI 
transamidase. Ohishi et al., (2000) showed GAA1 knockout cells were defective 
in the formation of carbonyl intermediates between precursor proteins and the 
transamidase. We have also found a TbGAA1 gene by using the BLAST 
program and TIGR-Database, which has a high homology with hGAA1 and 
yGAA1 and showed several transmembrane domains. It needs to be further 
characterized.  
 
Cellular localization using specific antibodies shows that TbGpi8 is mostly 
localized in the Golgi apparatus. Some other results, such as pro-VSG, which is 
mostly found within the ER, and VSG-hydrazid, which is transported from ER 
to the Golgi apparatus but not further to the plasma membrane, also provided 
some evidence for the localization of transamidase within the Golgi apparatus. 
Resident Golgi proteins must have localization signals to ensure that they are 
targeted to the correct Golgi compartment and not swept further along the 
secretory pathway. It may also be supposed that within the trypanosomal Golgi 
apparatus, the TbGaa1p form an enzyme complex with TbGpi8. Gpi8 contains 
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no KKXX and KDEL retrieval motifs, which are necessary and sufficient for the 
recycling of proteins from the Golgi complex to the ER. Lotti et al. (1999) 
indicated that proteins tagged with the KKXX motif are located along the entire 
early segment of the secretory pathway, i.e. ER, IC, and cis-Golgi complex, but 
are not confined within the ER. Some of them have been found located in the 
Golgi complex at steady state. The localization of TbGpi8 within the Golgi 
complex may also be mediated by such a protein with KKXX motif. Recent 
studies indicate that there are a number of different Golgi localization signals 
and mechanisms for retaining proteins within the Golgi apparatus such as 
oligomerisation, lipid-mediated sorting and intra-Golgi retrograde transport 
(Gleeson, 1998). More information is required to determine the Golgi 
localization of TbGpi8. 
 
It is believed that Gpi8 is the catalytic subunit (Yu et al., 1997). This protein 
shares significant homology with a family of previously characterized cysteine 
proteinases, the asparaginyl endopeptidases known as legumains (Benghezal et 
al., 1996), which were originally identified in the seeds of leguminous plants 
(Ishii, 1994). These proteins have been categorized as family C13 of cysteine 
peptidases (Riezman and Conzelmann, 1998). The GPI:protein transamidases 
belong to family C13 of the cysteine peptidases (Riezman and Conzelmann, 
1998) and they are likely to possess the classical catalytic dyad residues, 
cysteine and histidine, that mediate their activity. It has been shown that 
GPI:protein transamidase activity is susceptible to sulfydryl alkylating agents, 
implying that the protein has an essential cysteine (Sharma et al., 1999). This 
study of TbGpi8 in trypanosomal lysates showed also the efficient inhibition of 
the transamidase activity by pCMPSA. Two cysteine (Cys76 and Cys192, 
TbGpi8 numbering) and two histidine (His45 and His150) residues are 
conserved among trypanosomal, leishmania, yeast, and human GPI8 (Fig. 3.16). 
Both histidine residues are also conserved in legumain, whereas only one of the 
cysteine residues is conserved across all C13 family members (Cys192, TbGpi8 
numbering). Thus, this residue is the prime candidate for the active site cysteine. 
Meyer et al. (2000) proved that Cys199 and His157 in ScGpi8 are the active site 
residues. In TbGpi8, it is most likely that the two corresponding residues, 
Cys192 and His150, are the active site.  
 
The detected enzyme activity of the heterologously expressed TbGpi8 suggests 
that the enzyme is in its mature form, despite of its different apparent molecular 
mass. This difference might be due to an incorrect cleavage of MBP-TbGpi8 by 
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the used enterokinase or to a slightly different folding. Use of the recombinant 
TbGpi8 and the developed specific antibodies have provided important tools for 
the investigation of the transamidase mechanism of GPI anchoring, and the 













































The parasitic protozoan Trypanosoma brucei expresses a variant surface 
glycoprotein (VSG), which protects it from lysis by host serum components. All 
mature VSGs are N-glycosylated and glycosylphosphatidylinositol (GPI) 
anchored. 
 
To study trypanosome-specific post-translational modifications of VSG, a cell-
free system was produced by 'limited lysis' of bloodstream forms of 
Trypanosoma brucei. Newly formed proteins were labelled using 
[35S]methionine or biotinylated lysine. After in vitro translation and N-
glycosidase F treatment, a VSG with a slightly smaller apparent molecular mass 
appeared, indicating that newly synthesized VSG underwent translocation and 
glycosylation in this cell-free system. Biotinylated proteins were isolated by 
affinity chromatography from in vitro translation samples by using immobilized 
avidin. Specific anti-CRD antibodies were used successfully to demonstrate the 
existence of the GPI anchor on newly formed VSG. Appearance of mfVSG by 
inhibition of endogenous GPI-PLC with ZnCl2 and labeling of VSG with UDP-
[14C]galactose provided conclusive evidences for the linkage between in vitro 
translation and post-translational modification in our cell free system. 
 
It was supposed that GPI anchoring was processed by a transamidation reaction 
(Udenfriend et al., 1995). The transamidase mechanism of GPI anchoring was 
studied by culture of bloodstream form Trypanosoma brucei in media containing 
hydrazine or biotinylated hydrazine. Tunicamycin was also used in the media to 
form deglycosylated VSG, which allows analysis without interference of old 
VSG. In the presence of hydrazine, newly formed VSG was not detected with 
anti-CRD antibodies and in the presence of biotinylated hydrazine, newly 
formed VSG was detected by streptavidin, indicating that hydrazine or 
biotinylated hydrazine functioned as substitutes of GPI and thus covalently 
linked to the C-terminus of VSG. Intracellular localization of VSG in the cells 
cultured in the presence of hydrazine demonstrated that VSG was not transferred 
to the cell surface efficiently, because there are a few vesicles between cell 
nucleus and kinetoplast, which could be visualized by anti-VSG antibody very 
intensely. These results suggest the incorporation of nucleophilic agents during 
the transamidation reaction. Hence, the GPI anchor addition of VSG is catalysed 
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by a transamidase. Study of the transamidase activity in cell lysates using the 
synthetic substrate Ac-S-V-L-N-AMC showed a pH optimum of 5.5 and the 
activity could be stimulated by hydrazine and inhibited by pCMPSA, suggesting 
not only a transamidation reaction mechanism of the GPI anchoring but also a 
functionally sulfhydryl residue in the active centre of the transamidase. 
 
TbGpi8 was cloned and expressed in E. coli. TbGPI8 encodes for a 37 kDa or 35 
kDa protein if the signal sequence is removed. It has one potential N-
glycosylation site near the N-terminus. TbGpi8 shows a significant homology to 
other Gpi8ps, which belong to a novel cysteine protease family. Like LmGpi8, 
TbGpi8 has no C-terminal hydrophobic region. Homology between this family 
and other Cys proteinases, such as caspases, pointed to Cys192 and His150 as 
potential active site residues. Enzyme activity assays using heterologously 
expressed TbGpi8 and Ac-S-V-L-N-AMC showed cleavage of the substrate, 
indicating that Gpi8p is indeed directly involved in the proteolytic removal of 
the GPI anchoring signal. Intracellular localization of the TbGpi8 within the 
Golgi apparatus was observed by using specific anti-TbGpi8 antibodies, which 
were developed from chicken. This result allows to explaining the existence of 
pro-VSG within the ER and a transport block of VSG hydrazid from Golgi to 
cell surface. Western blotting analysis using anti-TbGpi8 antibodies 
demonstrated 3 protein bands of 37, 35 and 33 kDa. The 37 kDa band should be 
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